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Abstract 
Aim 
To measure the immediate effects of a brief mindfulness body scan meditation on 
self-reported pain, the nociceptive system and autonomic nervous system. 
 
Study design 
A between-subject, repeated measures, double-blinded, randomised controlled trial, 
with experimental and control interventions. A 10-minute intervention period was 
followed by a 15-minute rest period. 
 
Participants 
Thirty adults with chronic pain (7 men and 23 women) recruited through advertising in 
local papers, web-based social media and professional networks. 
 
Interventions 
The experimental group followed a 10-minute audio recording of a mindfulness based 
body scan meditation. The control group listened to a 10-minute audio recording of 
text from an audio book in a pleasant, friendly voice whilst sitting quietly. 
 
Main measures 
The primary dependent variable for self-reported pain was rating of pain severity on a 
visual analogue scale. The primary dependent variables for nociception were: 
pressure pain threshold recordings at a painful site and pressure pain threshold 
recordings at a non-painful site. The primary dependent variables for the autonomic 
nervous system were: mean heart rate, heart rate variability, heart rate variability low 
frequency to high frequency power ratio, and skin conductance.  
 
Results 
There were no statistically significant differences between the group that listened to 
the experimental mindfulness tape and the group that listened to the control tape on 
any of the outcome measures. 
 
Conclusion 
In people with chronic pain, a brief mindfulness body scan meditation has no effect 
on rating of pain severity on a visual analogue scale, pressure pain thresholds, mean 
heart rate, heart rate variability, heart rate variability low frequency to high frequency 
power ratio, or skin conductance when compared to a control group. Further research 
is required before determining whether brief mindfulness interventions are helpful in 
people experiencing chronic pain. 
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Abbreviations 
ACC Anterior cingulate cortex 
ANS Autonomic nervous system 
BPM Beats per minute 
BVP Blood volume pulse 
CRPS Complex regional pain syndrome 
ECG Electrocardiogram 
EEG Electroencephalogram 
EPSP Excitatory postsynaptic potentials 
fMRI Functional magnetic resonance imaging 
HF High frequency 
HR Heart rate 
HRV Heart rate variability 
IBI Interbeat interval 
LF Low frequency 
LF/HF Ratio between low frequency and high frequency band powers 
MBSR Mindfulness-based stress reduction 
MRI Magnetic resonance imaging 
NMDA N-methyl-D-aspartate 
NTS Nucleus tractus solitarius 
nuHF Normalised units of high frequency 
PAG Periaqueductal grey 
PBN Parabrachial nucleus 
PCS Pain catastrophising scale 
PEP Pre-ejection period 
PNS Parasympathetic nervous system 
PPT Pressure pain threshold 
RMSSD Square root of the mean squared differences between successive RR intervals 
RSA Respiratory sinus arrhythmia 
SCR Skin conductance response 
SFMPQII Short-form McGill pain questionnaire 
SNS Sympathetic nervous system 
STD HR Standard deviation of instantaneous heart rate 
VAS Visual analogue scale 
VLF Very low frequency 
VLM Ventrolateral medulla 
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Chapter 1: Objectives 
1.1. Aim 
The aim of this study was to measure the immediate effects of a brief mindfulness 
body scan meditation on self-reported pain, the nociceptive system and autonomic 
nervous system. 
1.2. Hypotheses 
A. A single session body scan meditation will reduce self-reported measures of pain. 
B. A single session body scan meditation will reduce the sensitivity of the 
nociceptive system. 
C. A single session body scan meditation will shift the autonomic nervous system to 
a less sympathetic dominant state. 
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Chapter 2: Literature review 
2.1. Introduction 
The purpose of this study was to measure the immediate effects of a brief 
mindfulness body scan meditation on self-reported pain, the nociceptive system and 
autonomic nervous system. Previous studies have shown that a body scan 
meditation can help to improve self-reported perceptions of pain [1] but no research 
has measured its direct influence on the nociceptive or autonomic nervous system. 
The following chapter will provide context for the role of mindfulness as a tool within 
pain management, nociception, and its relationship to the autonomic nervous system. 
The nociceptive system and autonomic nervous system (as it relates to pain) will be 
outlined in this chapter with rationale on how mindfulness might influence them 
together. 
2.2. Pain and nociception 
“Strictly speaking, pain is not in any organ, but in the mind, since only that can feel.” 
Dorman Steele, Human Physiology, 1872. 
2.2.1. Chronic pain in NZ 
Chronic pain can be its own disease with a distinct pathology unto itself. An estimated 
one in six people suffer from chronic pain in NZ [2]. Two-thirds (67%) of those 
reporting chronic pain have lived with chronic pain for 5 or more years and a quarter 
(27%) have lived with chronic pain for 40% or more of their lives [3]. Despite 
conventional healthcare utilisation, nearly half of people with chronic pain report their 
pain as not under control [4]. Pain can be associated with changes in the nervous 
system that can worsen over time [5] and can give rise to significant psychological 
and cognitive deficits [6]. 
 
The impact of chronic pain on health related quality of life is dramatic. Those 
reporting chronic pain have much poorer health and the sequelae of chronic pain can 
be widespread across multiple aspects of biopsychosocial function [2, 7]. Living with 
chronic pain can be challenging and people frequently look for ways to better self-
manage [2]. In NZ, nearly a third of those who reported chronic pain do not use any 
form of medical treatment (defined as medicines, pills, tablets, injections, or waiting 
for surgery) and it is suspected they have developed their own management 
approaches [2]. 
 
Whilst pain clinics and treatment services are available for people with chronic pain in 
NZ, these services can be costly and limited by the time of experienced personnel to 
deliver the services [7]. There are only a few multidisciplinary pain management 
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programs available in the country for the management of chronic pain and recent 
studies have highlighted the need for improvement in service delivery [2, 7]. 
2.2.2. Pain and the nociceptive system 
Pain is a complex perceptual experience influenced by a wide range of psychosocial 
factors, including emotions, social and environmental context; the meaning of pain to 
the person; beliefs, attitudes, expectations; as well as biological factors [6]. The 
biopsychosocial view of pain provides an integrated model that incorporates 
mechanical, neurophysiological, psychological, as well as the social variables which 
may cause and perpetuate pain [8]. At its base, some form of damage to tissue 
generates nociceptive input to the brain. The person then interprets the signal such 
as determining whether the pain is sharp, dull, aching or burning. This cognitive 
interpretation (or appraisal) attaches meaning to the pain and influences subsequent 
behaviour [6]. 
 
A distinction between pain and the neural mechanisms of nociception is important. 
Physiological pain starts in the peripheral terminals and is initiated by specialised 
sensory receptors, called nociceptors, innervating peripheral tissues, activated only 
by noxious mechanical, thermal or chemical stimuli. Nociceptors can be found in skin, 
mucosa, membranes, deep fascia, connective tissue of visceral organs, ligaments 
and articular capsules, periosteum, muscles tendons and arterial vessels [9]. These 
receptors are first-order afferent neurons making up the peripheral aspect of the 
nociceptive system. 
 
Activation of nociceptors by mild noxious stimuli generates fast excitatory 
postsynaptic potentials (EPSP) in second-order neurons that signal the onset, 
duration, intensity and location of the stimulus [10]. If the EPSP sends the second-
order neuron in the spinal cord over its threshold, the signal is transmitted to the 
cortex and the sensation of pain will be elicited. Activation of nociceptive pathways is 
subject to activity-dependent plasticity, which manifests as a progressive increase in 
the response of the system to repeated stimuli [10]. This comprises the central 
component of pain sensitisation. Second-order neurons are distributed along the 
dorsal horn of the spinal cord, organised according to the Rexed laminae [9]. The 
specific nociceptive neurons responding exclusively to noxious stimuli are found in 
laminae I, II, V and VI [9]. The sources of input for these neurons are high threshold 
Aδ nociceptive fibres, and heat and C-polymodal nociceptive fibres [9]. The spinal 
cord also contains excitatory and inhibitory interneurons, mostly located in laminae I 
to III, which synapse locally [11]. 
 
Pain is experienced at a physical level and an affective level. A model put forward by 
Melzack and Casey in 1968 embodies pain as a sensory-discriminative dimension, 
relating to spatial and temporal properties, a motivational-affective dimension, 
14 
 
incorporating tension, fear and autonomic events, and a cognitive-evaluative 
dimension of pain as a whole [12]. 
 
The anatomical pathways and cortical regions involved in nociception can also be 
divided into distinct systems. The lateral system participates directly in the sensory-
discriminative attribution of nociception and involves specific thalamic nuclei which 
project to the somatosensory cortex [9]. This system can differentiate between the 
locality and intensity of the incoming stimulus. 
 
The medial system involves the frontal cortex, anterior cingulate cortex (ACC), insula 
and hypothalamus and evaluates the motivational-affective and cognitive-evaluative 
dimensions of pain perception [13]. In contrast to the lateral system, the medial 
nociceptive system has less defined projections from the thalamus to the 
somatosensory cortex, including limbic structures such as the insula and ACC [14]. 
The ACC and the anterior insulae function as integrative structures during the 
experience and anticipation of pain [15]. It is for this reason the medial system mainly 
contributes to the motivation-affective component of pain [9]. The ACC plays a 
deterministic role in pain modulation and analgesia. This analgesic effect is mediated 
through interaction with other structures such as the orbitofrontal cortex, the 
amygdala and the periaqueductal grey (an area around the cerebral aqueduct) [16]. 
The ACC has been marked as an area of the brain significant to the habituation and 
attenuation of pain in a descending manner, triggering downstream opioid-dependent 
mechanisms, and dysfunctional habituation to pain may represent a risk factor for the 
development of chronic pain states [17]. 
 
The brainstem is another anatomical site linked to pain modulation [5]. Many dorsal 
horn projection neurons, such as those in lamina I, have axons that cross the midline 
of the spinal cord and project rostrally in the contralateral white matter to terminate in 
various brainstem nuclei [11]. These pathways are thought to underlie pain and 
temperature perception [11]. Areas of pain regulation have been identified in the 
midbrain, pons, and the medulla, especially around the periaqueductal grey [18]. 
These areas of the brain are rich in endogenous opioids and opioid receptors and 
they also give rise to fibre tracts that project to the dorsal horn of the spinal cord, 
where serotonin, norepinephrine and acetylcholine are released [13]. The action of 
these tracts is to inhibit and facilitate nociceptive input from afferents and/or output by 
nociceptive second-order neurons. Activation of these tracts results in inhibition of 
dorsal horn nociceptive structures, which are mediated by the activation of opioid-
releasing interneurons [17]. 
2.2.3. Mechanisms of chronic pain 
Chronic (or persistent) pain is defined as pain that persists for 3 months or more 
beyond the expected period of healing [2, 19]. It is regarded as having no 
15 
 
physiological purpose or adaptive value, in comparison to acute pain which has 
protective functions [20]. Nociceptive pain is initiated by tissue damage, whereas 
chronic pain frequently arises through changes to the central processing mechanisms 
of nociception [21].  
 
Persistent pain has characteristics that include increased amplitude of response to a 
given stimulus (hyperalgesia), pain elicited by normally innocuous stimuli (allodynia) 
and spontaneous pain in the absence of external stimuli [22]. Several changes to the 
nervous system underlie these phenomena, including alterations in nociceptor 
threshold for activation, plasticity in synaptic connections in the spinal cord dorsal 
horn, or changes in activation of descending inhibitory and facilitatory pathways [11]. 
Chronic pain also frequently presents with symptoms of paraesthesia, sensory 
deficits, autonomic disturbances, and motor disturbances [23], reflecting interaction of 
the nociceptive system with other central and autonomic components. 
 
Neuroplastic changes can occur on multiple levels along nociceptive pathways, from 
peripheral nociceptors to the cortex [24]. Neuroplasticity takes on two forms: 
modulation and modification [10]. Modulation means reversible changes in the 
excitability of primary sensory and central neurons. Modification means longer lasting 
alterations in the expression of neurotransmitters, receptors and ion channels; or 
alterations in the structure, connectivity and long term potentiation of neurons, such 
that the system is grossly modified, distorting its normal stimulus-response 
characteristics. 
 
Long term plastic changes are caused by repetitive afferent or incoming stimulation 
and can lead to hyperalgesia (exaggerated neuronal responses) for long periods after 
peripheral drive has subsided. Nociceptors exhibit peripheral sensitisation when there 
is a reduction in the threshold for activation, an increase in the response to a given 
stimulus, or the appearance of spontaneous activity [25]. After peripheral injury or 
sensitisation, peripheral nerves display ectopic discharge which may lead to an 
increased barrage of nociceptive signalling to the dorsal horn of the spinal cord with 
or without peripheral stimulus [26]. Increased nociceptive transmission is, in part, due 
to plasticity of the sodium channel populations in peripheral nerves after injury. They 
lower the threshold for activation to the spinal cord and this adds to the amplification 
of peripheral events. Nerve growth factor has also been shown to have a key role in 
the process of peripheral sensitisation [27]. Demyelination and abnormal trafficking of 
sodium channels occurs along the membrane of injured nerves as well as their 
uninjured neighbours. Ongoing peripheral sensitisation and activation causing 
persistent drive into the spinal cord can induce central hyperexcitability. 
 
Central sensitisation is an amplification of neural signalling within the central nervous 
system that elicits pain hypersensitivity [28]. N-methyl-D-aspartate (NMDA) receptors 
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found in the brain and spinal cord have lowered thresholds for activation following 
repetitive noxious input due to removal of the magnesium blockade of the receptor 
channels [10]. Under conditions where the stimulus is maintained, NMDA receptors 
have been implicated in the spinal events where responses of the dorsal horn 
neurons are significantly increased after repetitive peripheral stimulation despite the 
input remaining constant [22]. Wind-up is one of the mechanisms responsible for the 
amplification of neuronal discharge in the spinal cord; hence the brain will receive 
greater and longer duration input for a given stimulus. 
 
As the brain repetitively receives greater input of stimulus for longer duration, 
functional reorganisation of the cortex can  occur [5]. For example, for people 
suffering with complex regional pain syndrome (CRPS), a shrinkage of the cortical 
representational field of the affected limb was found and the extent of the shrinkage 
correlated highly with the intensity of pain and the magnitude of mechanical 
hyperalgesia [29]. Irrespective of the location, nature or course of different pain 
syndromes, the most common finding is a decrease of grey matter in the cingulate 
cortex, the orbitofrontal cortex, the insula and the dorsal pons [5]. 
 
Pain may also be altered because of dysfunctional brain changes which impair 
descending inhibition or facilitation. Intact descending inhibition and facilitation is a 
key component of modulation of the barrage of sensory input from the periphery that 
ascends to the brain [30]. In a study by Apkarian et al [31], 17 people with chronic 
back pain demonstrated brain atrophy and that the pathophysiology of chronic pain 
includes thalamo-cortical changes in nociceptive processing. 
 
Figure 1. Process of pain chronification 
In summary, pain chronification can be due to numerous modulatory mechanisms, 
such as effects at the nociceptor level with peripheral sensitisation, the wind-up 
phenomenon, central sensitisation, and changes in descending central modulation 
[10] (Fig. 1). The decrease of grey matter in brain regions which are highly associated 
with pain modulation could potentially lead to dysfunction in effective pain modulation 
[5]. Abnormal modulation of brain nociceptive systems, at first transient, but possibly 
becoming permanent, could in part explain the shift from acute to chronic pain. The 
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transition from acute to chronic pain is also known to be influenced by psychological 
processes [32]. 
2.2.4. Psychological factors 
The biopsychosocial model has been instrumental in the development of treatment 
approaches for chronic pain [33]. There is no one distinct model to encompass all 
aspects of pain and dysfunction, however the biopsychosocial view takes into 
account biomechanical, biochemical and psychological factors that contribute to the 
experience of pain (Fig. 2). The extent 
of the involvement of each factor may 
differ from person to person, 
depending on variables such as age, 
chronicity and personality [34]. 
 
Psychological models propose that the 
treatment for chronic pain also needs 
to address the cognitive aspects of 
pain. This is based on the principle 
that a prerequisite for pain perception 
is that attention is drawn toward a 
noxious stimulus, but once it has been 
attended to, cognitive processes have to interpret what that stimulus means. This 
cognitive process is highly intertwined with emotional processes and can influence 
how pain is experienced and described by a person [35]. For example, attention to 
pain can become linked to fear and anxiety, making the person hyper-vigilant and 
acutely aware of pain signals [32]. Therefore, attempting to suppress or attend to 
thoughts about pain actually increases the pain experience [36]. 
 
“Cognitive errors” are beliefs about oneself and situations that are distorted in a way 
which over-emphasises negative consequences. An example of such a cognitive 
error is catastrophising, which can be defined as an exaggerated, negative 
orientation toward pain where a relatively neutral event is irrationally made into a 
catastrophe [37]. In essence, the person imagines the worst possible outcome and 
accepts the worst outcome as a given result. Catastrophising has been reported to be 
associated with elevated pain reporting in clinical settings and poor outcomes in 
cognitive-behaviourally oriented programs [33]. 
 
Findings have shown that higher levels of catastrophising are uniquely related to 
greater pain intensity in chronic pain patients [38]. While the precise mechanism 
underlying the relationship between cognitive modulation and pain intensity is still 
unclear, catastrophic thinking about pain is significantly associated with increased 
activity in brain regions related to anticipation of pain, attention to pain, emotional 
Figure 2. The biopsychosocial model 
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aspects of pain and motor control [39]. Conversely, neuroimaging studies have 
shown that distraction techniques can reduce both sensory and affective components 
of pain due to reductions in activity of the insula, ACC, thalamus, somatosensory 
cortex as well as increases in pain modulation by the prefrontal cortex and brainstem 
[40]. Additionally, cognitive therapies have been shown to have small to moderate 
effects on pain and catastrophising immediately post-treatment [41]. 
 
Heightened focus on possible signals of pain might explain why seemingly small 
injuries result in intense pain. People with a high fear of pain show greater attentional 
bias toward pain-related information compared with those classified as having low 
fear of pain [42]. Therefore, attentional factors are important clinically because there 
are techniques that address such factors and could therefore reduce the perceived 
experience of pain. Distraction techniques, for example, can teach patients to shift 
their attention to stimuli other than pain, whereas interceptive exposure shifts 
attention toward the pain so that they become habituated to the pain signal [43]. 
 
People with chronic pain often develop negative expectations about their ability to 
exert control over their pain because expectations of resolution are not fulfilled [32]. 
The pain is continually competing for attentional resources and while sometimes long 
term sufferers develop strategies to manage their pain, people new to chronic pain 
are more susceptible to attentional disruption and higher levels of perceived pain [42].  
They frequently terminate efforts to develop new strategies to manage pain and 
instead turn to passive coping strategies such as inactivity or self-medication to 
reduce emotional distress [19]. 
 
While chronic pain may be a somatic representation of psychological distress, or may 
represent a heightened sensitivity to bodily sensations, people with chronic pain 
usually demonstrate poor coping mechanisms and struggle to adapt and manage 
their pain [44]. In a study that compared the psychological characteristics of people 
with discrete pain versus chronic idiopathic pain, the latter reported higher levels of 
anxiety, fear of pain, helplessness and magnification of the problem [44]. 
 
Psychological factors have been reported to be predictive of long-term disability for 
many pain syndromes as well as for pain severity, emotional distress and treatment 
seeking [45]. The findings of these studies provide support for the biopsychosocial 
model and suggest that addressing how people perceive physical sensations can 
influence the experience of pain. This was demonstrated in a NZ study investigating 
mindfulness and chronic physical illnesses. Participants’ experience of pain and 
discomfort lessened as a result of mindfulness training and they showed significant 
positive changes around rumination, catastrophising and helplessness, hence being 
better able to manage their pain [46]. 
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Psychological therapies are commonly offered after orthodox treatments have failed 
and the treatment goal shifts from one of removing the pain to managing the pain 
[41]. Cognitive methods such as mindfulness-based stress reduction are aimed at 
assessing the thoughts of pain and changing associations with them. It is usually a 
component of cognitive behavioural therapy delivered by experienced staff trained in 
these protocols. Mindfulness-based stress reduction can cost up to $600 per course 
and take up to 2 hours a week for 8 weeks to learn [47]. For some people this might 
not be achievable, precluding access to the intervention. Brief adaptations of the 
intervention could increase affordability and accessibility and assist people to improve 
their ability to control responses to stimuli, or come to accept them. 
2.3. Autonomic nervous system 
2.3.1. Pain-autonomic interactions 
The autonomic nervous system (ANS) is structurally and functionally positioned to be 
an interface between the internal and external environment, co-ordinating bodily 
functions to ensure homeostasis and adaptive responses to stress [48]. Recent 
research points toward an association between dysfunction of the ANS and chronic 
pain [49], suggesting that dysregulation of the ANS (increased sympathetic and/or 
decreased parasympathetic tone) has a critical role in initiating and perpetuating 
central sensitisation [50]. 
 
The ANS and nociceptive systems work in tandem as part of a central network to 
deal with environmental challenges, interacting at multiple levels, including the 
periphery, dorsal horn, brainstem and forebrain [51]. These areas receive convergent 
nociceptive and visceral input, containing groups of neurons that initiate autonomic 
and behavioural responses to various stimuli, and inhibit or facilitate responses to 
pain [51]. 
 
Primary visceroceptive afferents terminate mainly in lamina I and V [48] of the spinal 
cord and project to the cerebral cortex via the spinothalamic tract, the major pathway 
for transmission of nociceptive information [51]. Lamina I neurons arise from 
progenitors of autonomic interneurons, and ascending projections of lamina I 
synapse strongly to sympathetic cell columns of the thoracolumbar spinal cord, thus 
forming loops for somato-autonomic and viscera-autonomic reflexes [52]. 
 
Lamina I neurons also project to brainstem areas involved in autonomic responses 
[53]. Lamina I neurons extend into the spinal trigeminal nucleus caudalis and then 
projects to the nucleus tractus solitarius (NTS) in the medulla and parabrachial 
nucleus (PBN) in the pons, which is the main integration site for all homeostatic 
afferent activity [54]. From here, dense projections go to the periaqueductal grey 
(PAG) in the midbrain, and then on to the hypothalamus and central nucleus of the 
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amygdala [48]. Afferent information then reaches the thalamus, ACC (considered the 
limbic motor cortex) and the insula (considered the limbic sensory cortex) [54]. A key 
feature of the spinal and trigeminal nociceptive pathways is that they provide 
collaterals which converge at every level of brainstem visceral pathways [55]. 
 
Nociceptive inputs may trigger autonomic responses via the NTS, PBN, amygdala, 
hypothalamus and ventrolateral medulla (VLM) because nociceptive afferents 
activate neurons in laminae I and V of the thoracic and upper lumbar spinal cord, 
which project monosynaptically to preganglionic sympathetic neurons at the same 
spinal level [55]. This provides a basis for segmental sympathetic reflexes. Cell 
groups in the VLM and pons project to the hypothalamus, intermediomedial cell 
column and dorsal horn, and modulate autonomic responses; the PBN projects to the 
amygdala and thalamus which activates emotional and arousal responses. 
 
Two important locations for interaction between the nociceptive system and the ANS 
are the PAG and hypothalamus. The dorsolateral, lateral and ventrolateral columns of 
the PAG have reciprocal connections with autonomic centres of the lower brainstem 
and hypothalamus that regulate activity of peripheral autonomic pathways [56]. 
Stimulation of the PAG has been known to provide long term effective pain relief in 
certain populations [57] and the hypothalamus has a central role in the integration of 
autonomic responses and pain modulation, necessary for homoeostasis and 
adaptation to internal and external stimuli [48]. The hypothalamus can initiate 
nociceptive modulation and participate in autonomic control when activated by 
nociceptive inputs, having neurons that project to multiple areas including the PAG, 
PBN, NTS, VLM, raphe nuclei, as well as the dorsal horn and preganglionic nuclei 
[55], all of which are involved in nociceptive modulation. 
 
The balance between inhibition and facilitation of nociception is dynamic and can be 
altered in and by different behavioural, emotional and pathological states [58]. The 
lateral and dorsolateral columns of the PAG receive well localised, superficial 
nociceptive inputs from the spinal and trigeminal dorsal horns and initiate 
sympathoexcitatory (fight/flight) responses mediated by neurons of the VLM, which 
activate sympathetic preganglionic neurons controlling cardiovascular effects, such 
as tachycardia, hypertension and redistribution of blood flow [59]. In contrast, 
neurons of the ventrolateral PAG column, receiving poorly localised somatic, visceral 
and muscular inputs, initiate sympathoinhibitory responses like hypotension and 
bradycardia by projecting to the region of the medullary raphe containing cardiac 
vagal premotor neurons [48]. The PAG, via neurons in the VLM, including 
serotonergic raphe magnus neurons, exerts a dual modulatory control on nociceptive 
relay at the level of the spinal and trigeminal dorsal horns [55]. 
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Numerous brain areas including the ACC, insula, prefrontal cortex, somatosensory 
cortices, thalamus, basal ganglia, amygdala and brainstem structures such the PAG, 
exert influence on autonomic control during nociceptive processing [60]. These areas 
may not be activated simultaneously in all painful conditions, but will be more or less 
activated depending on the biomechanical, biochemical and psychological factors 
influencing the subjective experience of pain. Their activation will also be dependent 
upon the intensity, duration and location of nociceptive input. Cerebral arousal, 
alertness, attention and sensory processing of environmental stimuli are promoted by 
the ANS [60] and it plays a crucial role in pain modulation. 
2.3.2. Cortical-autonomic modulation 
In both lateral and medial pain system activation, the ANS plays a major role in 
developing the most appropriate immediate physiological reaction and long term 
adaptation [30]. Central control of sympathetic and parasympathetic output involves 
several interconnected levels of the neuraxis, including spinal, bulbopontine, 
pontomesencephalic and forebrain [61]. 
 
The forebrain level includes the hypothalamus and components of the anterior limbic 
circuit such as the insula, ACC and amygdala, which are involved in the integration of 
bodily sensation and emotion-related autonomic responses [48]. The 
pontomesencephalic level integrates autonomic control with pain modulation and 
behavioural responses to stress, hence the PAG is a critical component of the 
emotional motor system [62]. This brainstem network receives input from the medial 
prefrontal cortex and ACC, and projects to other brainstem areas that control 
behaviour-specific patterns of motor and autonomic responses, which modulates 
dorsal horn excitability to nociceptive input and the gain of spinal reflexes [62]. 
 
The prefrontal cortex provides the major forebrain input to the PAG. The medial wall 
of the prefrontal cortex projects to the dorsolateral column; the anterior cingulate 
gyrus to the lateral, ventrolateral and dorsomedial columns; and the posterior 
orbitofrontal and anterior insular cortices project to the ventrolateral column of the 
PAG [63]. The prefrontal cortex is concerned with maintaining expectations and 
modulating the anticipation of pain. It has been shown that activity in the PAG region 
is enhanced during the anticipation of pain [60]. This activity correlates significantly 
with activity in the dorsolateral prefrontal cortex, which triggers opioid release within 
the brainstem so that the descending pain modulating system inhibits transmission of 
nociceptive signals from the dorsal horn [60]. 
 
Attention can influence brainstem activity and hence nociceptive processing [60]. In a 
study by Tracey et al [64], high-resolution functional magnetic resonance imaging 
(fMRI) was used to investigate brain activation within the PAG to painful stimuli in 
healthy people. The participants were asked to either focus on or distract themselves 
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from the painful stimuli. During distraction, pain intensity ratings were reduced while 
PAG activation was significantly increased. The study [64] suggested that the PAG is 
a site for higher cortical control of pain modulation in humans and will also influence 
the ANS with its autonomic connections to the lower brainstem. 
 
The insula and ACC are both engaged in pain processing and high-level control of 
autonomic function [51]. The lamina I spinothalamocortical pathway projects to the 
viscerosensory insular cortex [51, 60] and is part of the lateral pain system involved in 
discriminative aspects of pain sensation. The insular cortex projects to many 
components of the central autonomic network including the amygdala, hypothalamus, 
PBN and NTS [65]. The right anterior insula is involved in sympathetic arousal 
associated with mental tasks [66] as well as changes in arterial pressure, heart rate, 
respiration, gastrointestinal motility, salivation, pupil dilation and piloerection [51]. 
This brain region receives numerous sensory inputs including touch and nociception 
[67]. A similar somatotopic organisation of pain processing has been shown in the 
basal ganglia, which is involved in cognitive, affective, motor and autonomic states 
[68] and therefore also serves the function of coupling pain with the most appropriate 
autonomic response. 
 
The ACC receives input from the medial pain system and is also directly involved in 
control of autonomic functions, such as arousal during volitional behaviour and 
effortful cognitive processing [60]. ACC pyramidal neurons project directly to 
subcortical brain regions associated with autonomic control, including the 
hypothalamus, PAG and pons [69]. The genual aspect of the ACC receives input 
from motivational regions, such as the prefrontal cortex and amygdala, and is a main 
source of input for the PBN, NTS, nucleus ambiguus, VLM and interomediolateral cell 
column [65, 69]. These areas elicit a variety of visceromotor responses when 
stimulated, including changes in blood pressure, heart rate and respiration; facial 
flushing, salivation, nausea, vomiting and bowel and bladder evacuation [51]. 
Although different tasks engage areas of the ACC, fMRI findings indicate that a 
common dorsal cingulate region is involved in autonomic control during cognitive 
processing [69]. 
2.4. Mindfulness 
2.4.1. Mindfulness based stress reduction 
Mindfulness has been broadly conceptualised as a state in which one is highly aware 
and focused on the reality of the present moment, accepting and acknowledging it, 
without getting caught up in thoughts that might catastrophise an experience or an 
emotional reaction to a situation [70]. 
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Mindfulness can be defined as a state of consciousness in which the person 
maintains a single pointed awareness focused on mental, interoceptive and 
exteroceptive experiences, distinct from outcome-based self-management strategies 
that aim for a definitive endpoint [71]. Mindfulness is a process devoid of striving or 
attachment to any goal [72]. 
 
The construct of mindful awareness or mindfulness meditation originated in early 
Buddhist documents but is neither religious nor esoteric in nature [73]. Western 
researchers and clinicians who have introduced mindfulness practice into health 
treatment programmes usually teach these skills independently of the religious or 
cultural origins because of Western society’s unfamiliarity with Buddhist traditions or 
vocabulary [74]. Nevertheless, mindfulness meditation could be considered a 
component of ancient practices such as Vipassana meditation and Zen meditation 
[75]. These meditations belong to the pole of mindfulness at one end, opposite to 
concentrative meditations such as Transcendental Meditation [76]. Concentration-
based approaches train people to restrict their focus of attention to a single stimulus 
such as a word, sound, object or sensation and when attention wanders, it is 
redirected to the object of meditation [77]. Mindfulness meditation, in contrast, only 
involves observation of changing stimuli as they arise, often directed toward the inner 
experiences of the person, like thoughts and emotions, and emphasizes a less goal-
oriented, non-judgmental observation [77]. 
 
Mindfulness-based stress reduction (MBSR) programmes were first developed in 
1979 by Jon Kabat-Zinn at the University of Massachusetts Medical Centre and are 
now the most frequently cited method of mindfulness training [77]. Typically such 
programmes entail an 8-week intensive intervention and there have been a number 
of controlled and uncontrolled studies performed assessing specific and nonspecific 
effects of mindfulness interventions [70, 78]. Originally the programmes were used 
alongside medical treatment for the management of chronic pain and stress-related 
disorders but have since been found to potentially benefit those with cancer, anxiety, 
depression, fibromyalgia and eating disorders amongst other conditions [79]. 
 
MBSR courses were first introduced in NZ in 2005 by Jim Carmody, a psychologist 
also from the University of Massachusetts Medical Centre, who trained health 
professionals to offer MBSR [46]. The courses are both effort and time intensive with 
eight 2½ hour night classes over 8 weeks, plus an additional full day retreat on a 
Sunday between weeks 6 and 8. In between sessions, trainees are also asked to 
complete a workbook and practice their learnings for up to 60 minutes a day, 6 days 
a week [46]. 
 
MBSR comprises mainly of three techniques. Firstly, the body scan meditation is a 
45-minute technique that involves a gradual sweeping of attention through the entire 
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body from feet to head, focusing non-critically on any sensation and using periodic 
suggestions of breath awareness and relaxation [1, 77]. The process includes 
noticing, but not reacting to pain, emotions, urges, thoughts and other feelings in the 
body [80]. When the person notices their mind start to wander into thoughts, 
memories or fantasies, the content of these feelings is briefly noted and then 
attention is returned to breath or the present moment. 
 
The second MBSR technique is sitting meditation. Participants are instructed to sit in 
a relaxed and wakeful posture with eyes closed, directing attention to the sensations 
of breathing [77]. Finally, the third technique is Hatha yoga practice, which includes 
breathing exercises, simple stretches, and posture designed to strengthen and relax 
the musculoskeletal system [1]. An important consequence of mindfulness practice 
with all three techniques is the realisation that most sensations, thoughts and 
emotions fluctuate, or are transient, passing by like waves in the sea [77]. 
 
Systematic reviews involving chronic conditions have shown that while there is 
preliminary evidence supporting the notion that MBSR may improve health related 
quality of life and coping mechanisms for people with chronic conditions, evidence is 
limited when it comes to specific reduction in pain [1, 70, 79, 81]. While there is 
evidence that MBSR can improve pain acceptance [81], there are few controlled 
studies supporting the reduction in specific pain symptomatology. 
 
Jon Kabat-Zinn, who first introduced the use of mindfulness for people with chronic 
pain, hypothesised that training in mindfulness would attenuate pain by altering 
emotional responses to pain and enhancing acceptance-related coping strategies 
[82, 83]. A clinical trial of 90 people with chronic pain found that mindfulness 
meditation training in the context of a 10-week MBSR program can be effective in 
reducing self-reports of pain and pain-related behaviours [82]. In a subsequent study 
of 51 people with chronic pain, who were unsuccessfully treated by conventional 
methods, Kabat-Zinn reported significant decreases in pain and reductions in mood 
disturbances after a 10-week MBSR program [74]. Kabat-Zinn then did a 4-year 
follow up study of 225 people with chronic pain, who were enrolled in an 8-week 
MBSR programme, which showed maintenance of pain improvement among 60-72% 
of the cohort; however, this study did not include a comparison group [84]. 
 
In a New Zealand study investigating the health benefits of mindfulness-based stress 
reduction for people living with chronic physical illnesses, participants reported 
improvement in physical and social functioning, as well as improvements in mental 
health, energy, vitality and overall general health as a result of mindfulness training 
[46]. The majority of participants in the study had conditions which gave rise to pain 
such as fibromyalgia, arthritis, migraines and headaches [46], but no studies specific 
to mindfulness and chronic pain have been conducted in this country. Additionally, 
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whilst the results of current trials of mindfulness in people with chronic pain have 
been encouraging, the studies have been limited by small sample sizes and 
heterogeneous samples of people, including populations with different ages and sites 
or types of pain [1]. 
 
As described previously, MBSR programmes range from 20 to 26 hours of session 
time and were designed by Kabat-Zinn to be long enough that people could grasp the 
principles of self-regulation through mindfulness and develop the skills to practice 
meditation on their own [74]. However, for some people, the circumstances of their 
condition or demands on time may mean that MBSR in its standard form will exclude 
them from the possibility of participating fully in a programme [85, 86]. Recent studies 
have investigated the effects of a brief mindfulness meditation of 15-minutes or less 
to prevent time being a barrier to participation in mindfulness and found no evidence 
that shortened versions of the programme are less effective [85]. In studies related to 
mindfulness and psychological outcomes, Carmody and Baer [85] examined whether 
shorter programme times could produce similar results to the 8 to 10-week 
programme. Comparisons suggested that reductions in the number of MBSR in-class 
hours may not necessarily lead to compromised outcomes. Also, it is possible for 
short term results to be maintained in the long term [1]. In a study by Grossman et al. 
[87], the short term benefits observed in a group of people with fibromyalgia who 
underwent a brief mindfulness intervention were maintained at a 3-year follow-up. In 
other studies, short term changes were seen in pain [88], the cardiovascular system 
[89] and emotional regulation [90]. 
 
As the necessity of a full length MBSR programme is questioned [85], attention is 
now focusing on the effects of a shorter mindfulness intervention for people with 
chronic pain [91-94]. There is preliminary evidence that mindfulness may assist 
people with psychosocial adaptation to pain, which might be longer lasting than the 
impact on pain symptoms [70]; however, some studies are limited by the use of 
uncontrolled study designs [70]. Kingston et al [91] addressed this limitation by 
introducing an active control in a randomized, single-blind trial. They used a 6-
session, 3-week meditation intervention and found increases in pain tolerance to a 
cold-pressor task. Control participants were trained in guided visual imagery – a self-
relaxation strategy that directs attention away from the present moment. Divided 
attention provides a good control for mindfulness and results showed an increase in 
pain tolerance for mindfulness participants. The authors questioned though whether 
the length of the study over a 3-week time frame may have influenced results [91]. 
2.4.2. Brief mindfulness and chronic pain 
Some researchers refer to brief mindfulness techniques as focused breathing [90] or 
acceptance-based intervention [93], rather than mindfulness. This is because some 
participants have had no previous training in all mindfulness techniques [90]. 
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However, to be consistent with terminology used in the literature, and as the 
teachings are based on the underlying principles of mindfulness, it will be referred to 
here as brief mindfulness. 
 
A literature search was undertaken to determine the effects of short-duration 
mindfulness interventions on pain and related outcomes using Medline, 
ScienceDirect, the Cochrane database, and references of retrieved articles for 
studies on brief mindfulness interventions of less than 3 days in people with chronic 
pain. Search terms included mindfulness, MBSR, mindfulness-based intervention, 
brief, short-term, and chronic pain. Inclusion criteria of the literature search comprised 
randomised control trials using a mindfulness meditation intervention specifically, as 
opposed other forms of meditation. Outcome measures included pain thresholds, 
pain tolerance, self-reported pain ratings, pain unpleasantness ratings, mindfulness 
awareness ratings, and distress scales. The search identified limited evidence 
specific to brief mindfulness interventions of 3 days or less and application for people 
with chronic pain [88]. Four controlled studies that met the inclusion criteria were 
identified and reviewed [88, 92-94]. One study was of 3 days duration while three 
were 10 to 20-minutes in length for the intervention. Two studies used a therapist 
trained in mindfulness and two studies used a therapist-free intervention delivery. A 
summary of comparison is provided in Table 1. Studies that did not relate specifically 
to pain or chronic pain, or looked at items such as psychological distress or quality of 
life, were excluded. 
 
Zeidan et al [94] studied the effects of a 3-day mindfulness intervention on 
experimentally induced pain. This study examined the analgesic effect of meditation 
on pain ratings of electrical stimulation before and after intervention. A threshold 
procedure was used to determine stimulus intensities associated with cutaneous 
threshold, low pain threshold and high pain threshold, to make sure the same degree 
of sensory experience occurred for each person. Cutaneous threshold was defined 
as the intensity at which the person first detected a sensation, and subsequent pain 
thresholds were determined by progressively increasing electrical current by 5 to 
10mA. Math distraction and relaxation intervention were used as active controls in a 
within-group comparison. Results showed that 3 days of mindfulness meditation was 
effective in reducing pain ratings to experimentally induced pain. Participants 
reported less pain to both low and high pain intensities when meditating compared 
with cutaneous threshold before meditation. The authors also reported reductions in 
state anxiety after each meditation session, which additionally has the ability to 
attenuate feelings of pain. Each training session was held in a group setting of up to 8 
people and lasted approximately 20-minutes while an instructor taught different 
meditation skills. On the second day of the intervention, participants meditated to a 
standardised audio emphasising how moment to moment awareness can alter the 
experience of internal and external events. The mindfulness instruction was delivered 
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by a facilitator with more than 10 years of experience in mindfulness meditation 
techniques over 3 days. Whilst experienced therapists facilitate the quality of the 
intervention provided, this can lead to problems when trying to implement the 
intervention into everyday practice. For example, there are limited therapists available 
with the expertise to provide the intervention which can make it difficult for people 
access, together with accompanying costs and travel which may not be funded. 
 
Two studies measuring the effects of mindfulness on pain reduced the time frame to 
a single session, in a therapist-free form, delivering the intervention instructions 
through pre-recorded voices [88, 92]. The studies were published a month apart in 
2012 and were the first of their kind to test a therapist-free, short term intervention. 
The potential benefit of a therapist-free intervention is twofold: 1. to reduce the time a 
participant would have to spend in an MBSR course, and 2. to provide opportunity for 
people to learn mindfulness without the need for experienced trainers. 
 
In the first study, Liu et al [92] explored the effects of a brief mindfulness intervention 
in healthy college students on pain tolerance and distress of pain, measured by their 
response to experimentally induced cold-pressor pain. This cold-pressor technique 
can be used to screen participants who are not distressed by pain by excluding those 
who are able to keep their hand in ice water for more than 5 minutes [95, 96]. The 
reason for this is to increase the power of the experimental intervention for those who 
are more distressed by pain [93]. Twenty people were excluded from Liu’s [92] study, 
leaving a final sample of 60 females with a mean age of 20 years. 
 
The study was a double blind, randomised controlled trial involving healthy 
undergraduate students. The sample comprised female students only who were not 
currently experiencing pain from a medical condition. They compared three types of 
coping strategies on experimentally induced pain: mindfulness, distraction, and 
spontaneous coping. Each intervention was given using pre-recorded audios and 
lasted for 15 minutes. Results showed that compared with using spontaneous 
strategies, the mindfulness intervention significantly improved pain tolerance and 
reduced immersion distress. The distraction strategy also significantly improved pain 
tolerance; however, it did not have a significant effect on the level of distress during 
the immersion period. 
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Table 1. Summary of study comparison 
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In the second therapist-free study by Ussher et al [88], which was also a randomised 
controlled trial, the sample group consisted of patients attending an outpatient pain 
clinic in south west London who were diagnosed with a chronic pain condition. 
Participants were randomly allocated to intervention and control groups. The 
intervention was delivered using a pre-recorded audio therefore removing any effects 
from a therapist. Fifty-five from 86 people were recruited to the study and over 75% of 
them were females with low back pain. Results showed a significant reduction in 
ratings for pain related distress and for pain interfering with social relations for the 
intervention group compared with the control group. The findings support the results 
of the study by Liu et al [92] and suggest that chronic pain can alter the way 
nociception is processed [10]. 
 
The final study by Masedo et al [93] compared acceptance versus suppression of 
pain in a brief mindfulness study. A much larger sample was used than in Liu et al’s 
[92] study, comprising 219 participants with a more or less equal distribution of males 
(48%) to females (52%). Acceptance is the same idea as mindfulness whereby a 
person is actively contacting physical and psychological experiences, behaving 
effectively and not avoiding feelings [97]. Acceptance means to change the target for 
control from uncontrollable events (pain) to controllable factors, such as behaviour 
during the experience of pain, to lead to better daily function [93]. Suppression 
implies thought-stopping, which paradoxically can lead to an increase in intrusive 
thoughts and the experience of pain [98]. Suppression is different to distraction and 
therefore is a good differential in mindfulness comparisons. Thought-stopping 
involves recognising an inappropriate thought, emotion or sensation, silently yelling 
stop, then breathing deeply and exhaling slowly [93]. 
 
Masedo et al [93] used a single session, randomised controlled trial design. They 
found that the cold-pressor task was a less distressing experience for the acceptance 
group than the suppression group and improved pain tolerance time. This finding is 
congruent with Liu et al’s [92] results and two other studies looking at the effects of 
brief mindfulness on pain [88, 94]. However, Liu et al’s study [92] failed to 
demonstrate a main effect on pain ratings for each intervention, which is in contrast to 
Masedo et al’s [93] finding that the acceptance strategy produced lower subjective 
pain and distress ratings than distraction or spontaneous coping. A possibility for this 
is due to direct therapist interaction during each intervention. Masedo et al [93] 
compared acceptance, spontaneous coping and suppression strategies in a single 
session to control pain, and even though the therapists were blinded to the 
hypothesis, each intervention was scripted word by word to each participant for 
approximately 20 minutes [93] and this can help participants to learn the strategies 
more effectively and make adjustments accordingly [92]. 
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There are three fundamental differences among the final three studies. Firstly, the 
intervention used by Ussher et al [88] was specifically a body scan meditation, as 
opposed to a general mindful acceptance of feelings or sensations. A body scan is 
different to other common mindfulness techniques such as sitting or walking 
meditations [88]. A person’s attention is guided to specific body parts in turn and 
instructed to acknowledge sensations in each area without attempting to change 
them. Body scans are often used as an accessible entry point to mindfulness 
meditation [99]. Secondly, the mindfulness intervention was delivered twice over a 
24-hour period in the Ussher et al [88] study: once in a clinic setting and once in the 
participant’s normal home environment. Results showed that in the clinic setting, for 
the body scan group compared with the control group, there was a significant 
reduction in ratings for pain related distress and for pain interfering with social 
relations; however, in the participants’ home environment, none of the scored 
changes were significantly different between the groups [88]. Thirdly, Ussher et al 
[88] made use of subjective measures by creating a series of 4 questions evaluating 
pain ratings and 6 questions examining underlying processes of mindfulness. These 
10 items were drawn from the Brief Pain Inventory, the Chronic Pain Acceptance 
Questionnaire, and the Mindful Attention Awareness Scale. Participants completed 
ratings for these 10 items immediately before and after each intervention. Masedo et 
al [93] and Liu et al [92] utilised pain and distress ratings but did not include any 
ratings for mindful awareness. Ussher et al [88] reported that more than three 
quarters (78%) of people in their study rated the body scan as being a useful tool for 
helping them manage chronic pain. While this study was strong on subjective 
assessment and analysing the immediate effects of a mindfulness body scan 
meditation on pain ratings, little is known about the effects on the nociceptive system. 
 
Two of the four studies compared a brief mindfulness intervention to distraction [93, 
94]. Liu et al [92] found that distraction improves pain tolerance, but not as well as 
mindfulness. Distraction might have different effects on chronic pain in the short term 
and it is important that these effects were compared to mindfulness. Liu et al [92] 
reported that people who generally had longer pain tolerance times tried to distract 
their attention away from pain by creating a mental image of a happy scene. The 
authors decided to use this strategy in their study instead of the more common 
distraction technique of solving math problems, such as Zeidan et al [94] incorporated 
in their brief mindfulness study. Zeidan et al [94] found math distraction to reduce 
pain ratings when compared to relaxation, but mindfulness meditation was still shown 
to be more effective in attenuating pain ratings than both distraction and relaxation. 
Turning one’s attention away from pain and pain-related thoughts is in contrast to the 
basis of mindfulness meditation, which is to teach people to feel emotions and bodily 
sensations more fully and without avoidance [93], so therefore distraction is a good 
control when analysing coping strategies. Ussher et al [88] used distraction by having 
the control group listen to a 10-minute audio recording of natural history text read in a 
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pleasant voice. This has previously been found to be acceptable in controlling the 
effects of attention when used as a control condition in comparison with a body scan 
[100, 101]. 
 
In summary, the studies reviewed demonstrate that mindfulness meditation delivered 
in short form of 3 days or less, without the need for a trained therapist, can be 
beneficial in reducing tolerance time of pain under experimental conditions and 
reduce pain and distress ratings for people with chronic pain. This has potential 
widespread benefit for people in pain that cannot afford the time or cost of an 8-week 
MBSR programme. Outcome measures with regards to pain, however, have been 
subjective appraisals and to date little is known about the direct influence of brief 
mindfulness on the nociceptive system. 
2.4.3. Mindfulness and nociception 
Mindfulness meditation has been shown to be effective in the reduction of pain 
symptoms [75], however the transformation of nociceptive information into the 
subjective experience of pain, and then the modulation of pain, is a complex process 
with overlapping sensory, cognitive and affective dimensions [12]. Little is known 
about how the brain, brainstem and spinal cord regions involved in mindfulness 
interact with nociceptive processing. Mindfulness meditation is also associated with 
the modulation of sensory representations via emotional regulation [90], so 
delineating direct nociceptive mechanisms involved in mindfulness-related pain 
modulation remains unclear. 
 
The nociceptive system can be assessed using quantitative sensory testing and 
functional imaging. Pain measurement consists of psychophysical, psychological and 
physiological tools of measurement that evaluate pain thresholds, tolerance, pain-
related behaviours, and pain-related autonomic events [102]. Quantitative sensory 
tests are psychophysical in nature, with an objective physical stimulus but a 
subjective report from the person as the response [103]. 
 
Mechanosensitivity is one of the most commonly used criterion to classify response 
properties of nociceptive neurons in the central nervous system and tenderness to 
blunt pressure may be due to peripheral or central sensitisation [104]. Most 
polymodal nociceptors have excitation thresholds below the pain threshold and 
exhibit adaptation within a few seconds of stimulation, but pain from noxious pressure 
typically increases with longer lasting stimuli [105], reducing the threshold for 
nociceptor activation, potentially leading to peripheral and central sensitisation [25]. 
People with chronic pain typically have lower pain thresholds than in healthy matched 
controls [106] and Imamura et al [106] suggest that pain may not only be restricted to 
painful areas, with sensitivity to pressure also being present at sites distant to the 
painful area. Pain located in structures away from the source of pain is defined as 
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referred pain and, as a central phenomenon, has been recognised for years, 
frequently used for diagnostic purposes [107]. 
 
Pressure pain threshold (PPT) is defined as the minimal amount of mechanical 
pressure that produces pain [108]. Quantitative measurement of pain thresholds due 
to blunt pressure is performed most commonly using pressure algometry with the aid 
of a hand-held device [104]. The devices most often used for this purpose are the 
pressure threshold meter and the pressure pain algometer, which both have a 
circular rubber pad of 1cm
2
 for contact with the skin. They can be either spring-loaded 
or electrical with a pneumatic pressure gauge. The pressure algometer is placed 
perpendicular to the skin and pressure is applied at a constant rate. Recommended 
pressure application rates range from 0.05 to 20N/s, applied to allow the person time 
to react when pain is felt [108]. The action of pressure is stopped when the person 
reports feeling pain. 
 
No studies to date have examined the effects of mindfulness on nociception using 
PPT measurement; however, two studies used functional imaging to assess the 
neural mechanisms by which mindfulness meditation can influence pain [109, 110]. 
 
Zeidan et al [110] used fMRI to investigate how mindfulness meditation affects pain-
related brain processes. In a controlled trial, brain activity was compared in 15 
healthy adults in the presence of noxious thermal stimulation, before and after 4 days 
of meditation training. Prior to being taught mindfulness meditation, participants were 
familiarised with the sound of the MRI machine and the sensation of thermal stimuli. 
In the pre-meditation session, participants were tested by alternating application of 
noxious thermal stimuli (49°C) and neutral stimuli (35°C) to the calf, at rest, and with 
attention to breath, thereby providing a control for mindfulness meditation. After 4 
days of meditation training, participants were tested again, yet this time instructed to 
meditate by focusing on the changing sensations of breath in the presence of thermal 
stimuli administered again in alternating patterns of heat and neutral temperatures of 
12 seconds duration. Meditation produced a 40% reduction in pain intensity ratings 
compared with rest and significantly reduced pain unpleasantness ratings by 57%. 
Meditation reduced pain-related activation of the contralateral primary somatosensory 
cortex and increased activity in the ACC and anterior insula. Participants with the 
greatest reductions in pain intensity ratings exhibited the largest meditation-induced 
activation of the right anterior insula and bilateral ACC, while those with the greatest 
reductions in pain unpleasantness ratings exhibited greatest activation of the orbital 
frontal cortex and greatest deactivation of the thalamus. 
 
These findings indicate a possible substrate for pain modulation. Meditation-related 
activation in these executive-level cortical areas may influence thalamic nociceptive 
processing [110]. Activation in higher order brain regions, such as the prefrontal 
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cortex, can regulate lower sensory processes, specifically in the thalamic reticular 
nuclei [83], thus inducing a gating mechanism which modulates ascending noxious 
information before accessing cortical regions implicated in conscious perception 
[110]. In a functional imaging study by Dickenson et al [109], it was shown that 
focused breathing significantly increased activity in the fronto-parietal regions, pre-
supplementary motor area, anterior insula and ACC. The prefrontal cortex is likely to 
be a pivotal source of pain modulation as it receives sensory information from all 
modalities and is associated with limbic affective-motivational structures. The ACC 
also employs control mechanisms to modulate pain through activation of the 
descending opioid system via the PAG [83]. This aids opioid-mediated analgesia 
acting on the level of the spinal cord dorsal horn, which is why it is important to 
measure pressure pain thresholds using mechanosensitivity. Mindfulness might 
modulate pain perception via pain-specific opioid-sensitive descending modulatory 
pathways, reducing the excitability of dorsal horn neurons [111]. 
2.4.4. Mindfulness and the ANS 
The autonomic nervous system plays a critical role in regulating cardiovascular 
responses to mental and physical stress. The balance between sympathetic and 
parasympathetic regulation of the cardiovascular system is crucial to blood pressure 
stability and long term health. The sympathetic nervous system (SNS) elevates heart 
rate and blood pressure via adrenergic activity whereas the parasympathetic nervous 
system (PNS) slows the heart through cholinergic actions focused at the sinoatrial 
node [112]. There is a close relationship between cortical functions and 
cardiovascular health, and clinical studies have shown networks in the brainstem and 
forebrain to influence autonomic outflow and cardiovascular control [112, 113]. 
 
Indices of autonomic function including heart rate, heart rate variability (HRV), skin 
conductance/resistance, respiratory rate, and electroencephalogram (EEG) activity 
have become biomarkers for monitoring meditative states [114]. HRV that is related 
to respiration is known as respiratory sinus arrhythmia (RSA) and is a good index of 
vagal activity at the cardiac sinoatrial node under most non-stressful conditions [115]. 
Hence, it is an indicator of PNS activity directed at the heart. RSA is a rhythmical 
fluctuation in heart periods at the respiratory frequency that is characterised by 
shortening and lengthening of heart periods in phase with inspiration and expiration 
respectively [116]. RSA is quantified in people using a vagal tone monitor with a 
moving polynomial filter to assess beat-to-beat HRV in the adult respiratory frequency 
band [89]. Estimates of low frequency (0.06 to 0.10Hz) and high frequency (0.12 to 
0.40Hz) HRV are often used as an index of cardiac sympathetic activity and 
parasympathetic activity, respectively [117]. A number of researchers have noted that 
the magnitude of RSA is influenced not only by outgoing vagal activity but variables 
such as respiratory frequency, depth, and stimulation of oxygen and carbon dioxide 
sensitivity [89]. 
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In a study by Phongsuphap et al [118], it was shown that HRV during concentration 
meditation can change from a normal state in a systematic way. During meditation, 
the power spectrum of RR (beat-to-beat) intervals tends to shift toward a specific 
location of frequency to form a resonant peak. This shift in power has a number of 
health benefits, such as resetting baroreflex sensitivity, increasing parasympathetic 
tone and improving efficiency of gas exchange in the lung [118]. The power spectrum 
for short time series can be classified into three ranges [119]: very low frequency, low 
frequency and high frequency, with the higher frequency being primarily modulated 
by PNS activity. In Phongsuphap et al’s [118] study, for some cases it was shown 
that the resonant peak appeared in the high frequency range during meditation, 
which means that HRV is synchronised to respiratory rhythm, indicating that 
meditation can increase parasympathetic tone [120]. A resonant peak during 
meditation reflects a state of coherence, meaning synchronisation among different 
physiological oscillatory systems such as heart, respiratory, and blood pressure 
rhythms [121]. Coherence during mediation has the potential benefit of resetting 
baroreceptor sensitivity involved in short-term blood pressure control [120]. 
 
Wallace [122] was among the first to report that conditioning procedures such as 
meditation can alter autonomic functions and provide evidence that heart rate, skin 
conductance response (SCR) and blood pressure can be controlled using meditation. 
Oxygen consumption, heart rate, skin resistance and electrocardiogram (ECG) 
measurements were recorded before, during and after a single 30-minute session of 
meditation in 15 healthy college students with experience in meditation. Significant 
changes were shown between the meditation and control period in all measurements. 
Oxygen consumption decreased by 20% and remained low during meditation, 
coupled with a decrease in frequency of breath or tidal volume; skin resistance 
increased markedly at the onset of meditation, with some rhythmical fluctuations 
during meditation; and ECG recordings showed a mean decrease of 5 beats per 
minute in heart rate, indicating an increased PNS activity directed at the sinoatrial 
node. 
 
Different forms of meditation have different effects on autonomic function and heart 
rate dynamics [123]; therefore, understanding the physiological effects of various 
aspects of mindfulness meditation becomes important in deducing which forms are 
more beneficial for reducing sympathetic activity. Two recent studies compared the 
short term effects of mindfulness meditation on autonomic and cardiovascular 
function to relaxation techniques [89, 114]. Both investigated common autonomic 
indices in the first experiment of each study. In the second experiment, Ditto et al [89] 
measured pre-ejection period (a measure of cardiac sympathetic activity), while Tang 
et al [114] used EEG activity to monitor ACC activity. 
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Ditto et al [89] compared the body scan meditation to progressive muscular relaxation 
and to a wait-list control group in 32 healthy young adults with no previous 
experience in meditation. In the first part of the study, individuals participated in 2 
sessions, scheduled 4 weeks apart. The body scan group were guided in a therapist-
free form using a tape, guiding the listener to attend to various parts of the body, 
breathing and observing, allowing thoughts to recede for 20 minutes. The progressive 
muscular relaxation also listened to a tape and practiced techniques that involve 
tensing and relaxing different muscle groups, while the wait-list control group were 
tasked to sit quietly for an equal period of time. Autonomic indices measured included 
heart rate, HRV and RSA. 
 
Ditto et al [89] found that individuals who practiced mindfulness meditation displayed 
significantly larger baseline-to-treatment increases in RSA than the wait-list control 
group and the muscular relaxation group. Thus, the body scan meditation appeared 
to have enhanced PNS activity and this result did not require extensive practice – 
results showed immediate physiological effects. Heart rate also decreased during the 
20-minute treatment period; however, none of the interventions (meditation, muscular 
relaxation, or just sitting) reduced blood pressure either immediately or over the 1-
month period. Another part to the study was then conducted where participants 
served as their own control. Fifteen of 30 healthy young adults practiced mindfulness 
meditation during the first session and then listened to a control audio tape in the 
second session, whereas the other half of the group listened to the audio tape first 
and then practiced mindfulness second. This within-subject design was aimed at 
reducing generalisation of results from the first study. Additional cardiovascular 
measures such cardiac pre-ejection period (PEP) were obtained using an Ambulatory 
Impedance Monitor. 
 
PEP, a systolic time interval of ventricular depolarisation, is a non-invasive measure 
which reflects cardiac contractility, a function primarily controlled by beta-adrenergic 
mechanisms or cardiac sympathetic activity [124]. PEP is useful in 
psychophysiological research since measurement of heart rate alone does not 
indicate whether vagal or sympathetic influences are changing autonomic function 
[124]. Ditto et al [89] found reductions in PEP during meditation, suggesting that 
meditation may produce an increase in cardiac sympathetic activity. Sometimes heart 
rate is not altered during meditation, when it would be expected to decrease, and this 
might be due to the beta-adrenergic influence of PEP [89, 124]. In some cases, 
experienced meditators exhibit an increase in low frequency HRV reflecting increased 
sympathetic activity [118, 123]. These findings suggest that complex changes occur 
in the autonomic nervous system during meditation and that it is not simply a state of 
rest. Meditation involves active, arousal-promoting processes as well as relaxing 
processes [89]. 
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Tang et al [114] investigated the short-term effects of meditation on central and 
autonomic nervous system interaction in 86 Chinese undergraduate students over 5 
days, comparing meditation to relaxation. Forty-six people participated in the first 
experiment, measuring autonomic indices such as heart rate, SCR and respiratory 
rate; and in the second experiment, 40 people participated using the same autonomic 
indices plus EEG recordings. After 5 days of mindfulness training, results from 
experiment 1 showed a reduction in SCR, heart rate, chest respiratory rate, as well 
as more high-frequency HRV. According to the authors, these factors indicate better 
ANS regulation, especially more PNS activity during and following mindfulness 
training in comparison with relaxation [114]. 
 
Recent neuroimaging studies have demonstrated that sympathetic outflow to the 
heart is modulated by the activity of the ACC [112]. Tang et al [114] hypothesised that 
activity in the ACC increases during mindfulness training because it serves as part of 
an executive attention network involved in the control of cognition and emotion [125]. 
To explore these brain mechanisms during short-term meditation, Tang et al [114] 
recorded brain activity using EEG and single photon emission computed tomography 
(SPECT) to obtain temporal and spatial information on ACC activity. After 5 days of 
training, global brain activity was reduced in the meditation group, however more 
regional cerebral blood flow was shown in the right ACC. To show the relationship 
between brain activity and physiological indices, the authors performed correlations 
between changes in the frontal midline theta power and high-frequency HRV. High-
frequency HRV is associated with parasympathetic control of the ANS, and ACC 
activation correlated significantly with this, suggesting ACC influence on PNS activity. 
In contrast, relaxation produced more frontal, temporal and parietal activations than 
mindfulness, possibly due to the high level of brain activation required during effortful 
control in relaxing different parts of the body [114]. Differentiating between cortical 
influence on PNS and SNS still remains unclear as the two systems are tonically 
active and operate in conjunction with each other. However the results from Tang et 
al [114] are consistent with other studies which indicate that mindfulness meditation 
and the medial prefrontal cortex is directly involved in human cardiovagal control 
[112], increases parasympathetic activity [114], and does not require a significant 
amount of training. 
 
Mindfulness could be a useful strategy for chronic pain but little has been done to 
examine the short-term effects of mindfulness on the ANS of this population. Brief 
mindfulness techniques require limited training. Therefore, if chronic pain is driven or 
reinforced by alterations in autonomic function, then people with chronic pain could 
benefit from techniques that are able to mitigate these alterations. 
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Chapter 3: Method 
3.1. Introduction 
The purpose of this study was to measure the immediate effects of a brief 
mindfulness body scan meditation on self-reported pain, the nociceptive system and 
autonomic nervous system in people with chronic pain. The mindfulness intervention 
was compared to a control intervention. The following chapter outlines the method 
used in the research by describing the study design, participants, procedure, 
interventions, outcome measures, data management and statistical analysis. 
3.2. Study setting and design 
This study was undertaken at Spinewave Wellness Centre, a private practice in 
Remuera, Auckland, NZ. A between-subject, repeated measures, double-blinded, 
randomised controlled trial with experimental and control interventions was used. 
3.3. Study participants 
3.3.1. Sample size 
The sample size calculation was undertaken using an alpha level of 0.05 and power 
of 0.8 using G*Power 3.1.3 [126]. A prior power calculation for an F test using 
G*Power revealed that for a moderate effect size of 0.3, with 2 groups, N = 24 
participants will be required. An effect size of 0.3 was selected based on a similar 
previous study in this field that showed a significant reduction in pain after a 10-
minute session of mindfulness in people with chronic pain [88]. An effect size of 0.3 
will account for 9% total variance within the sample [127]. The sample size was 
increased to 30 participants (or 15 per group) as the effect size of the intervention on 
autonomic system outcome measures was uncertain but estimated to be lower. 
3.3.2. Recruitment 
Participants were sourced from advertising in local papers, web-based social media 
and through professional networks. The newspaper advertisement (Appendix D) 
included the study title, brief information on the study, eligibility criteria and an 
invitation to volunteer. 
3.3.3. Inclusion and exclusion criteria 
Participants were included in the study if they satisfied the following inclusion criteria: 
 
 Aged over 18 years. 
 Diagnosed by a clinician with a chronic pain condition such as fibromyalgia, 
complex regional pain syndrome, neuralgia, or general longstanding chronic pain 
like back, neck, leg or arm pain. 
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 Had experienced pain for at least 3 months.  
 
Participants were excluded if they had any of the following: 
 
 Previously engaged in mindfulness-based programmes because experienced 
meditators exhibit greater effect on the autonomic nervous system than novices 
[118]. 
 Unstable heart condition or pacemaker due to unwanted beat-to-beat signals 
[128]. 
 Unstable health condition as this could confound results of the experiment. 
 Head pain, since pressure pain thresholds cannot be recorded on the head. 
 Poor hearing or poor command of the English language, since the interventions 
required listening to and understanding an audio file. 
 Prescribed and taking psychotropic medication as this could confound results of 
the experiment [88]. 
 Social issues that precluded them from attending the session, such as lack of 
transport or family commitments. 
 Inability to provide informed consent. 
3.4. Ethical and cultural considerations 
Ethical approval was obtained from the AUT University Ethics Committee (AUTEC), 
approval number 13/354 (Appendix A). During the design and implementation of the 
study the principles of the Treaty of Waitangi, including partnership, participation and 
protection were applied, and the recruitment process ensured that all eligible 
participants had equal opportunity to take part in the study regardless of ethnicity. 
Each participant was fully informed with a participant information sheet (Appendix E) 
and consented to participating in the study by signing a consent form (Appendix F), 
being aware that they had equal chance of being in either the experimental or control 
group. The privacy of each participant was maintained at all times by assigning 
participant codes. 
3.5. Study procedure 
The following section describes the study procedure, including pre- and post-
intervention outcome measures, experimental and control interventions (Fig. 4). 
 
Volunteers contacted the researcher via e-mail or telephone after learning of the 
study through the recruitment procedures used, as outlined above (see 3.3.2). At this 
point, each volunteer was screened for inclusion and exclusion criteria, as well 
discussing the nature of their pain. Each participant was then e-mailed the participant 
information sheet (Appendix E) to be informed of the purpose of the study and its 
procedure in writing. Eligible participants were invited to attend one session at the 
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clinic. At this session participants were asked for personal details including age, 
gender, handedness and pain condition, and provided written informed consent 
(Appendix F). The nature of each participant’s pain was assessed prior to the 
intervention using the Pain Catastrophising Scale (see 3.5.1) and the Short-Form 
McGill Pain Questionnaire II (see 3.5.2). 
 
The study was a double-blinded, 
randomised controlled trial; therefore, 
both participants and the researcher were 
blinded to the intervention received. 
Participants were informed during the 
screening process that they had equal 
chance of being in the intervention group 
or the control group. If a participant was 
randomised to the control group, they 
were offered an opportunity to undergo 
the real mindfulness body scan at the 
completion of the study if it was shown to 
be beneficial. 
 
Participants were told an audio file would 
be played for them whilst they were sitting 
quietly and they were asked to listen to 
the instructions (Fig. 3). Participant 
grouping was randomised using a 
computer generated random list within 
Microsoft Excel (2010). The interventions 
were provided on an audio file following a standardised procedure which allowed the 
researcher to remain blinded. Two audio files, labelled Tape A and Tape B, were sent 
to the researcher and loaded onto a laptop. The audio file delivered to each 
participant through headphones contained either the experimental or control 
intervention and was played without the researcher present in the room.  
 
Two outcome measures of pain were recorded at baseline (before the intervention), 
immediately following the intervention, and 15 minutes after the intervention. The first 
was a rating of pain severity on a visual analogue scale (VAS) (see 3.7.2) and the 
second was PPT at a site of pain on the body and at a control or non-painful site (see 
3.7.1). 
 
While the audio file was playing, physiological data was constantly recorded. Four 
autonomic indices were recorded continuously from baseline (before the intervention) 
through to 15 minutes following the intervention. These were blood volume pulse (see 
Figure 3. Participant positioning 
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3.7.3), heart rate (see 3.7.4), heart rate variability (see 3.7.5), and skin conductance 
response (see 3.7.6). 
 
Figure 4. Procedure outline 
3.5.1. Pain Catastrophising Scale 
As pain catastrophising affects how individuals experience pain, the Pain 
Catastrophising Scale (PCS) was used to assess pain catastrophising within the 
sample. The PCS is a 13-item tool derived from definitions of catastrophising and can 
be completed in less than 5 minutes [129] (Appendix B). 
 
People who catastrophise tend to do three things, all of which are measured by this 
questionnaire: 1. They ruminate about their pain (“I can’t stop thinking about how 
much it hurts”); 2. They magnify their pain (“I’m afraid that something serious might 
happen”); and 3. They feel helpless to manage their pain (“there is nothing I can do to 
reduce the intensity of my pain”) [37]. 
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A total PCS score of 30 out of 52 corresponds to the 75
th
 percentile of PCS scores in 
samples of people with chronic pain and represents a clinically relevant level of 
catastrophising [129]. People who score between the 50
th
 and 75
th
 percentile on the 
PCS are considered at moderate risk for the development of chronicity. 
Catastrophising not only contributes to heightened levels of pain and emotional 
distress, but also increases the probability that the pain condition will persist over an 
extended period of time [129]. 
3.5.2. Short-Form McGill Pain Questionnaire 
The nature and sensitivity of a pain condition can influence results. The Short-Form 
McGill Pain Questionnaire II (SFMPQII) helps describe the level of pain participants 
are experiencing. The main component of the SFMPQII consists of 22 descriptors of 
pain rated on a Likert scale from 0 to 10 (Appendix C).  
 
The first Short-Form McGill Pain Questionnaire (SFMPQI), developed by Melzack 
[130], includes visual analogue and verbal rating scales, as well as 15 pain 
descriptors. The SFMPQII was expanded upon to include seven additional 
descriptors so that it would provide a comprehensive assessment and 
characterisation of the symptoms of both neuropathic and non-neuropathic pain 
[131]. Studies by Dworkin et al [131] suggest the SFMPQII provides reliable and valid 
support for four components of pain: continuous pain, intermittent pain, neuropathic 
pain, and affective descriptors. 
 
The total Pain Rating Index score is obtained by summing the item scores from the 
SFMPQII. A higher score on the SFMPQII indicates worse pain [132]. The Pain 
Rating Index is interpreted in terms of quantity of pain, as evidenced by the number 
of words used and the rank of value for each word, as well as the quality of pain, 
defined by the particular words that are chosen [132]. 
3.6. Experimental and control interventions 
3.6.1. Mindfulness body scan meditation 
The body scan meditation intervention was a brief 10-minute audio recording that 
guided the attention of the participant through their entire body, focusing non-critically 
on any sensation and using periodic suggestions of breath awareness and relaxation 
[1, 77]. The instructions asked participants to acknowledge all sensations without 
attempting to change them by practising mindful acceptance [88]. The process 
included noticing, but not reacting to pain, emotions, urges, thoughts and other 
feelings in the body [80]. When the person noticed their mind start to wander into 
thoughts, memories or fantasies, the content of these feelings was briefly noted and 
then attention returned to breath or the present moment. 
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3.6.2. Control intervention 
To control for the potential influences of pure relaxation as people take time out of the 
day to sit in a quiet room and listen passively to a person speaking in a pleasant 
voice, an audio recording of a narrator reading a section of Dan Brown’s book “The 
Lost Symbol” [133] was used as a control intervention. The section of the audio book 
used holds the listener’s attention but is not exciting. This type of control has 
previously been found to be acceptable in countering the effects of attention when 
used as a control condition in comparison with a body scan meditation [88, 89]. 
3.7. Outcome Measures 
3.7.1. Pressure pain threshold 
Pressure pain threshold (PPT) is defined as the minimal amount of mechanical 
pressure applied to a specific body that produces pain [108]. A simple handheld 
pressure algometer (Lafayette Manual Muscle Testing System, Model 01165, USA) 
was placed perpendicular to the tissue surface at two standard locations and 
pressure applied steadily at a constant rate. One location was a nominated site of 
chronic pain and the other a non-painful site on the opposite limb or trunk. When the 
participant reported feeling pain during application, the action of pressure was 
stopped and the maximum pressure achieved recorded. Each location was assessed 
twice before the intervention (baseline), immediately following the intervention, and 
15 minutes after the intervention (Fig. 11). The two PPT readings taken at each 
interval were averaged and recorded, i.e. two PPT recordings at the painful site and 
two PPT recordings at the non-painful site. 
3.7.2. Visual analogue scale 
The visual analogue scale (VAS) is a subjective, psychometric measure of pain. A 
participant is asked to indicate his or her perceived pain intensity along a 100mm 
horizontal line. The left end of the line is marked with “no pain” and the right end 
“worst pain imaginable” (Fig. 5). The distance of the rating measured from the left 
edge produces the VAS score. 
 
 
Figure 5. Visual analogue scale 
Changes in the VAS score represent a relative change in the magnitude of pain 
sensation. The VAS has properties consistent with a linear scale; thus, if the VAS 
score is halved after a clinical intervention, then the person’s pain is halved [134]. 
The VAS score correlates well with acute pain levels but has an error of 
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approximately 20mm [134]. Each participant recorded their VAS score before the 
intervention (baseline), immediately following the intervention, and 15 minutes post 
intervention. For the two post-intervention measures, the participants were not able to 
see their previous score(s) while rating their current score. 
3.7.3. Blood volume pulse 
Blood volume pulse (BVP) was measured using a photoplethysmograph and 
indicates dynamic changes in blood volume underneath the sensor. BVP is not an 
outcome measure itself but is used as the application to estimate heart rate and HRV. 
The BVP signal indicates relative changes in the vascular bed due to vasodilation or 
vasoconstriction (increases or decreases in blood perfusion), as well as changes in 
the elasticity of the vascular walls, which may correlate with changes in blood 
pressure [128]. The photoplethysmograph was placed over the ring finger (Fig. 6) of 
the non-dominant hand, as the index and middle fingers were used for recording the 
SCR. BVP was recorded at 128Hz using a NeXus-10 MKII and BioTrace software 
(MindMedia, Netherlands). 
3.7.4. Heart rate 
The volume of blood in the arteries and capillary beds increases with each arterial 
pulsation. Heart rate (HR) can be estimated from the BVP signal [128]. HR is the 
number of heart beats per minute (bpm) and is calculated by measuring the time 
interval between the heart beats, or the interbeat interval. The time of the interbeat 
interval is divided into 60 seconds to calculate the beat-by-beat HR. 
 
 
Figure 6. Photoplethysmograph (BVP) placement 
3.7.5. Heart rate variability 
HRV is the amount of HR fluctuation around the mean HR [119]. HRV describes 
variations of both instantaneous HR and beat-to-beat intervals that can be analysed 
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using time or frequency domain methods [135]. Cardiac cycles centred on the tone of 
the sinoatrial node produce rhythms which are modulated by central oscillations (e.g. 
respiratory centres) and peripheral oscillations (e.g. blood pressure) that are 
influenced by autonomic activity [119]. Spectral analysis of HRV examines these 
frequency-specific oscillations. Estimates of low frequency (0.06 to 0.10Hz) and high 
frequency (0.12 to 0.40Hz) HRV are often used as an index of cardiac sympathetic 
activity and parasympathetic activity respectively [117]. Low frequency (LF) power 
divided by high frequency (HF) power produces an LF/HF power ratio, which is 
considered an indicator of sympathovagal balance [136] with relative normal limits 
falling between 1.0 and 2.0 [119]. Very low frequency (VLF) HRV is strictly greater 
than 0.00Hz but less than 0.04Hz [137]. The physiological explanation of the VLF 
component of HRV is not well defined [119] and is usually attributed to non-harmonic 
properties that reflect slow, regulatory mechanisms such as thermoregulation [138]. 
For this reason VLF is usually avoided when interpreting short term ECG recordings 
[119] and subtracted from the total power of LF and HF (Table 2). Normalised 
spectral HRV measures express quantities on a percentage scale basis and 
normalised units of high frequency (nuHF) HRV is the index of modulation of 
parasympathetic activity [137]. A higher score indicates greater parasympathetic 
activity; therefore, nuHF was used as the main HRV outcome measure in this study. 
3.7.6. Skin conductance response 
The SCR is a momentary increase in the electrical conductivity of the skin associated 
with increased sweat gland activity [139]. The SCR is typically measured from the 
palmar surface of the hand where eccrine sweat gland density is greatest. A pair of 
electrodes was placed on the palmar tips of the index and middle fingers of the non-
dominant hand [140] after sites had been pre-treated with ethanol wipes (Fig. 7). A 
small direct electrical current passes through the electrodes and measures 
conductance through the skin. As sweat glands become more active, electrical 
conductivity of the skin momentarily increases resulting in a SCR, typically ranging 
between 0.1 and 2.0 micro Siemen (µS) units [139]. A lower score shows more 
parasympathetic activity [114]. The SCR is elicited by stimuli that are novel, 
unexpected, intense, complex or emotionally arousing [139]. The SCR was recorded 
at 32Hz using a NeXus-10 MKII and BioTrace software (MindMedia, Netherlands). 
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Figure 7. SCR electrode placement 
3.8. Data processing 
Autonomic indices were recorded continuously without interruption during the 10-
minute intervention and 15 minutes post intervention using NeXus-10 MKII and 
BioTrace software (MindMedia, Netherlands). A total of 25 minutes of raw data (SCR, 
BVP and HR) were recorded with BioTrace (Fig. 8). Autonomic variables were 
processed in 5 epochs of 5-minute intervals. These were then grouped to match the 
pain time epochs (Fig. 11). Epoch 1 and 2 spanned the 10-minute intervention, and 
epochs 3, 4 and 5 spanned the 15-minute rest period after the intervention. 
 
 
Figure 8. Raw data trace from Biotrace 
Raw interbeat interval (IBI) data were obtained from the BVP trace (Fig. 8) using 
BioTrace’s HRV analysis function. IBI data, including any artefacts, were exported in 
ASCII text file format to Kubios HRV (Biosignal Analysis and Medical Imaging Group, 
Finland). 
46 
 
 
Kubios HRV is advanced software for studying the variability of heart beat intervals 
[141], including time-domain (Fig. 9) and frequency-domain (Fig. 10) variables of 
HRV. 
 
Figure 9. Time-domain variables of HRV in Kubios 
The following time-domain variables were recorded for analysis: Mean heart rate 
(mean HR), standard deviation of instantaneous heart rate values (STD HR), and the 
square root of the mean squared differences between successive RR intervals 
(RMSSD), which can be used as a measure of short term variability [141]. 
 
 
Figure 10. Frequency-domain variables of HRV in Kubios 
The generalised frequency bands for short term HRV recordings are VLF (0-0.04Hz), 
LF (0.04-0.15Hz) and HF (0.15-0.4Hz) [141]. In frequency-domain methods, a power 
spectrum density estimate is calculated for RR interval series and frequency bands 
are extracted from this. Frequency bands extracted for this study were: absolute and 
relative powers of LF and HF bands; LF and HF band powers in normalised units 
(nuLF, nuHF); the LF/HF power ratio; and peak frequencies for each band (Table 2). 
 
SCR data, measured in micro Siemens (µS), were exported in ASCII text file format 
to Microsoft Excel (2010). Data for the 25 minutes of total recording were divided into 
5-minute epochs as discussed previously and the average of 9,600 samples was 
entered for each epoch. This provided an average of the SCR response over time. 
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Table 2. Frequency domain measures 
Measure Units Description 
   
Peak frequency Hz VLF, LF, and HF band peak frequencies 
Absolute power ms
2 
Absolute powers of VLF, LF, and HF bands 
Relative power % Relative powers of VLF, LF, and HF bands 
  VLF (%) = VLF (ms
2
) / total power (ms
2
) x 100% 
  LF (%) = VLF (ms
2
) / total power (ms
2
) x 100% 
  HF (%) = VLF (ms
2
) / total power (ms
2
) x 100% 
Normalised power nu Powers of LF and HF bands in normalised units 
  LF (nu) = LF (ms
2
) / (total power [ms
2
] - VLF[ms
2
]) 
  HF (nu) = LF (ms
2
) / (total power [ms
2
] - VLF[ms
2
]) 
LF/HF  LF/HF Ratio between LF and HF band powers 
Note: Hz = hertz; VLF = very low frequency; LF = low frequency; HF = high 
frequency; ms
2
 = milliseconds squared; nu = normalised units. 
 
PPT readings, recorded in Newtons, and VAS measurements, recorded in 
millimetres, were spread into 3 epochs: baseline, immediately post intervention (10 
minutes), and 15 minutes post intervention (Fig. 11). Two PPT readings were taken 
at each interval and averaged for the painful site and non-painful site. One VAS 
measurement was recorded at each interval. 
 
 
Figure 11. Timeline of assessments 
3.9. Data analysis 
All data, including autonomic and pain variables, was then entered into SPSS (SPSS 
220.0 for Windows, SPSS Inc., USA) for analysis. Following completion of the study, 
the researcher was unblinded to the interventions. Tape A was the experimental 
intervention and Tape B was the control intervention.  
 
Analysis involved two phases. Firstly, a descriptive analysis of the participants’ 
characteristics and baseline variables of interest were performed for each group. 
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Comparisons between the two groups for each variable were performed using t-test 
and chi-square test. 
 
Secondly, a generalised linear model using repeated measures over 3 time epochs 
(Fig. 11), with “tape” (intervention) as a between factor, was used to analyse the pain 
outcome measures. The primary dependent variables for pain were: PPT recordings 
at the painful site, PPT recordings at the non-painful site, and VAS measurements. 
 
Additionally, a generalised linear model using repeated measures over 5 time 
epochs, with “tape” (intervention) as a between factor, was used to analyse the 
autonomic data. Note that epoch 1 and 2 spanned the intervention period and epochs 
3, 4 and 5 spanned the rest period after the intervention. The primary dependent 
autonomic variables were: mean HR, nuHF, LF/HF ratio, and SCR. 
 
The estimate of the intervention effect was adjusted for potential confounding effects 
of the following covariables: age, gender, PCS and SFMPQII scores. A p value of 
less than 0.05 was considered significant. 
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Chapter 4: Results 
4.1. Introduction 
The following chapter presents the main findings of the study. It will provide an 
overview of recruitment and retention, followed by a description of the participants’ 
characteristics. Finally, analysis of the effect of the interventions on self-reported 
pain, the nociceptive system and autonomic nervous system will be presented. 
4.2. Recruitment and retention 
Thirty-six people volunteered for the study. One participant was excluded for having a 
pacemaker. Of the 35 meeting the inclusion criteria, four did not respond to follow-up 
calls to finalise participation and one did not show for her session. Thirty participants 
(n = 15 per group) completed the 10-minute intervention and 15-minute rest period 
(Fig. 12). Data collection took place from September 2014 to April 2015. 
 
 
Figure 12. Recruitment and retention 
4.3. Sample characteristics 
The age of participants ranged from 25 – 81 years, with 7 male and 23 female 
participants. Five people were left handed and 25 right handed. Eligible participants 
presented with the following chronic pain conditions: 9 with musculoskeletal pain, 5 
with fibromyalgia, 3 with spinal pain, 9 with arthritis, 3 with neuropathy, and 1 with 
complex regional pain syndrome. 
 
The mean PCS score of participants for the current study was 19 (48
th
 percentile) 
with a maximum of 45 (97
th
 percentile) and a minimum score of 2 (5
th
 percentile). 
Eight participants scored between the 50
th
 and 75
th
 percentile and 4 participants 
scored above the 75
th
 percentile. The PCS score was shown to influence self-
reported measures of pain (4.4) and mean HR (4.6.1). 
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For the purpose of this study, participant’s total SFMPQII score was summed to 
indicate the person’s current level of pain. The mean SFPMQII score was 70, with a 
maximum score of 188 and minimum of 13. The SFMPQII score was shown to 
influence PPT of the painful site (4.5.1), PPT of the non-painful site (4.5.2), mean HR 
(4.6.1), high frequency HRV (4.6.2), and LF/HF power ratio (4.6.3). 
 
As shown in Table 3, there were no significant differences between the groups at 
baseline before listening to either Tape A (experimental intervention) or Tape B 
(control intervention).  
 
Table 3. Comparison of groups at baseline 
Variable Tape A Tape B Statistical Test p value 
     
Age, Mean (SD) 59.13 (16.41) 60.47 (11.58) T-Test 0.799 
PCS, Mean (SD) 20.47 (9.43) 17.47 (11.72) T-Test 0.446 
SFMPQII, Mean (SD) 64.40 (36.63) 75.20 (43.60) T-Test 0.469 
Gender, N (%) 
Male 
Female 
 
 
5 (33) 
10 (66) 
 
 
3 (25) 
12 (75) 
 
 
Chi-Square Test 
 
 
0.341 
 
Handedness, N (%) 
Right 
Left 
 
 
12 (80) 
3 (20) 
 
 
13 (87) 
2 (13) 
 
Chi-Square Test 0.500 
Note: Tape A = experimental intervention; Tape B = control intervention; SD = 
standard deviation; PCS = Pain Catastrophising Scale; SFMPQII = Short-Form 
McGill Pain Questionnaire II; N = number of participants. 
4.4. Self-reported pain 
Comparison of experimental (Tape A) and control (Tape B) interventions for self-
reported measures of pain using VAS scores is represented in Figure 13. Results are 
presented in Table 4. The estimate of the intervention effect was adjusted for 
potential confounding effects of age, gender, PCS and SFMPQII scores. 
 
There was no significant main effect of intervention (β = -0.081, p = 0.986), of time 
post intervention (β = -8.233, p = 0.145), of time 15 minutes post intervention (β = -
6.833, p = 0.227), or interaction effect of intervention x time (β = 2.333, p = 0.846) on 
VAS scores. 
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Figure 13. VAS self-reported measures of pain 
Note: VAS = Visual Analogue Scale; error bars = standard error of the mean; 
mm = millimetres. 
 
Table 4. Statistical model results for VAS scores showing intervention and time 
effects/interaction with covariables that were retained in the model 
Variable β  (SE) p value 
   
Tape A -0.081 (4.716) 0.986 
Time, Post intervention -8.233 (5.651) 0.145 
Time, 15 min post intervention -6.833 (56.651) 0.227 
Tape x Time interaction 2.333 (12.042) 0.846 
PCS score 0.708 (0.225) 0.002 
Gender, Male -8.643 (5.279) 0.102 
Note: VAS = Visual Analogue Scale; β = beta; SE = standard error; Tape A = 
experimental intervention; PCS = Pain Catastrophising Scale. 
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PCS scores were significantly associated with VAS scores (β = 0.708, p = 0.002), i.e. 
for each PCS point increase, the VAS score increased by 0.708mm. There appeared 
to be an influence of gender (β = -8.643, p = 0.102), i.e. males were associated with 
lower VAS scores across all time epochs. SFMPQII scores and age were not 
associated with VAS scores therefore not retained in this statistical model. 
 
These results do not support the hypothesis that a single session body scan 
meditation will reduce self-reported measures of pain for people with chronic pain. 
4.5. Nociceptive system 
4.5.1. PPT of the painful site 
Comparison of experimental (Tape A) and control (Tape B) interventions for pressure 
pain thresholds at the participant’s nominated painful site is represented in Figure 14. 
Results are presented in Table 5. The estimate of the intervention effect was adjusted 
for potential confounding effects of age, gender, PCS and SFMPQII scores. 
 
 
Figure 14. PPT recordings of the painful site 
Note: PPT = pressure pain threshold; error bars = standard error of the mean; 
N = Newton. 
 
There was no significant main effect of intervention (β = 6.567, p = 0.184), of time 
post intervention (β = 6.433, p = 0.277), of time 15 minutes post intervention (β = 
7.757, p = 0.190), or interaction effect of intervention x time (β = 4.233, p = 0.769) on 
PPT of the painful site. 
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Gender was significantly associated with PPT (β = 33.201, p < 0.001), i.e. the mean 
PPT was 33.2N higher among males than females across each epoch. SFMPQII 
scores were significantly associated with PPT of the painful site (β = -0.178, p = 
0.004), i.e. every increase in the Pain Rating Index was associated with a reduction 
of PPT by 0.178N. PCS scores and age were not associated with PPT of the painful 
site therefore not retained in this statistical model. 
 
Table 5. Statistical model results for PPT of the painful site showing 
intervention and time effects/interaction with covariables that were retained in 
the model 
Variable β  (SE) p value 
   
Tape A 6.567 (4.938) 0.184 
Time, Post intervention 6.433 (5.922) 0.277 
Time, 15 min post intervention 7.757 (5.922) 0.190 
Tape x Time interaction 4.233 (14.431) 0.769 
SFMPQII score -0.178 (0.062) 0.004 
Gender, Male 33.201 (5.531) 0.001 
Note: PPT = pressure pain threshold; β = beta; SE = standard error; Tape A = 
experimental intervention; SFMPQII = Short-Form McGill Pain Questionnaire II. 
 
These results do not support the hypothesis that a single session body scan 
meditation will reduce the sensitivity of the nociceptive system for people with chronic 
pain. 
4.5.2. PPT of the non-painful site 
Comparison of experimental (Tape A) and control (Tape B) interventions for pressure 
pain thresholds at the participant’s nominated non-painful site is represented in 
Figure 15. Results are presented in Table 6. The estimate of the intervention effect 
was adjusted for potential confounding effects of age, gender, PCS and SFMPQII 
scores. 
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There was no significant main effect of intervention (β = 4.912, p = 0.428), of time 
post intervention (β = -3.997, p = 0.591), of time 15 minutes post intervention (β = -
4.938, p = 0.507), or interaction effect of intervention x time (β = -0.740, p = 0.967) on 
PPT of the non-painful site. 
 
Gender was significantly associated with PPT (β = 27.203, p < 0.001), i.e. the mean 
PPT was 27.2N higher among males than females across each time epoch. SFMPQII 
scores were significantly associated with PPT of the non-painful site (β = -0.390, p < 
0.001), i.e. every increase in the Pain Rating Index was associated with a reduction in 
PPT by 0.39N. PCS scores and age were not associated with PPT of the non-painful 
site therefore not retained in this statistical model. 
 
 
Figure 15. PPT recordings of the non-painful site 
Note: PPT = pressure pain threshold; error bars = standard error of the mean; 
N = Newton. 
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Table 6. Statistical model results for PPT of the non-painful site showing 
intervention and time effects/interaction with covariables that were retained in 
the model 
Variable β  (SE) p value 
   
Tape A 4.912 (6.202) 0.428 
Time, Post intervention -3.997 (7.438) 0.591 
Time, 15 min post intervention -4.938 (7.4379) 0.507 
Tape x Time interaction -0.740 (17.871) 0.967 
SFMPQII score -0.390 (0.781) 0.001 
Gender, Male 27.203 (6.946) 0.001 
Note: PPT = pressure pain threshold; β = beta; SE = standard error; Tape A = 
experimental intervention; SFMPQII = Short-Form McGill Pain Questionnaire II. 
 
These results do not support the hypothesis that a single session body scan 
meditation will reduce the sensitivity of the nociceptive system for people with chronic 
pain. 
4.6. Autonomic nervous system 
4.6.1. Mean heart rate 
Comparison of experimental (Tape A) and control (Tape B) interventions for mean 
HR is represented in Figure 16. Results are presented in Table 7. The estimate of the 
intervention effect was adjusted for potential confounding effects of age, gender, PCS 
and SFMPQII scores. 
 
There was no significant main effect of intervention (β = -2.632, p = 0.100), of time 
post intervention (β = 0.301, p = 0.845), or interaction effect of intervention x time (β = 
-1.548, p = 0.682) on mean HR. 
 
Those who listened to the experimental intervention showed a non-significant trend (p 
= 0.100) of reduced mean HR of 2.632bpm across all 5 time epochs. Gender was 
significantly associated with mean HR; males displayed a higher HR (8.946bpm) over 
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all epochs (p < 0.001). There was a significant decrease of 0.417bpm for an increase 
in age by one year (p < 0.001) and a significant increase of 0.075bpm for each Pain 
Rating Index point (SFMPQII; p = 0.003). There appeared to be an influence of PCS 
scores on mean HR (β = -0.177, p = 0.056). 
 
 
Figure 16. Mean HR 
Note: Intervention = epoch 1 and 2; post intervention = epochs 3, 4 and 5; Hz = 
hertz; HR = heart rate. 
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Table 7. Statistical model results for mean HR showing intervention and time 
effects/interaction with covariables that were retained in the model 
Variable β  (SE) p value 
   
Tape A -2.632 (1.599) 0.100 
Time, Post intervention 0.301 (1.539) 0.845 
Tape x Time interaction -1.548 (3.774) 0.682 
PCS score -0.177 (0.093) 0.056 
SFMPQII score 0.075 (0.025) 0.003 
Age -0.417 (0.057) 0.001 
Gender, Male 8.946 (1.732) 0.001 
Note: HR = heart rate; β = beta; SE = standard error; Tape A = experimental 
intervention; PCS = Pain Catastrophising Scale; SFMPQII = Short-Form McGill 
Pain Questionnaire II. 
 
These results do not support the hypothesis that a single session body scan 
meditation will shift the ANS to a less sympathetic dominant state for people with 
chronic pain. 
4.6.2. High frequency HRV 
Comparison of experimental (Tape A) and control (Tape B) interventions for 
percentage of change in the normalised unit of high frequency HRV (nuHF) is 
represented in Figure 17. Results are presented in Table 8. The estimate of the 
intervention effect was adjusted for potential confounding effects of age, gender, PCS 
and SFMPQII scores. 
 
There was no significant main effect of intervention (β = -1.355, p = 0.657), of time 
post intervention (β = -4.593, p = 0.137), or interaction effect of intervention x time (β 
= 1.553, p = 0.821) on nuHF. 
 
It was found that age was significantly associated with nuHF (β = 0.546, p < 0.001), 
i.e. nuHF increased by 0.546% with an increase in age by one year. SFMPQII scores 
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were also significantly associated with nuHF (β = 0.093, p = 0.019), i.e. nuHF 
increased by 0.093% for each Pain Rating Index point. PCS scores and gender were 
not associated with nuHF therefore not retained in this statistical model. 
 
 
Figure 17. High frequency HRV in normalised units 
Note: Intervention = epoch 1 and 2; post intervention = epochs 3, 4 and 5; nuHF 
= normalised units of high frequency; HRV = heart rate variability. 
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Table 8. Statistical model results for nuHF showing intervention and time 
effects/interaction with covariables that were retained in the model 
Variable β  (SE) p value 
   
Tape A -1.355 (3.052) 0.657 
Time, Post intervention -4.593 (3.085) 0.137 
Tape x Time interaction 1.553 (6.861) 0.821 
SFMPQII score 0.093 (0.039) 0.019 
Age 0.546 (0.113) 0.001 
Note: nuHF = normalised units of high frequency; β = beta; SE = standard error; 
Tape A = experimental intervention; SFMPQII = Short-Form McGill Pain 
Questionnaire II. 
 
These results do not support the hypothesis that a single session body scan 
meditation will shift the ANS to a less sympathetic dominant state for people with 
chronic pain. 
4.6.3. LF/HF power ratio 
Comparison of experimental (Tape A) and control (Tape B) interventions for LF/HF 
power ratio is represented in Figure 18. Results are presented in Table 9. The 
estimate of the intervention effect was adjusted for potential confounding effects of 
age, gender, PCS and SFMPQII scores. 
 
There was no significant main effect of intervention (β = -0.464, p = 0.233), of time 
post intervention (β = -0.084, p = 0.831), or interaction effect of intervention x time (β 
= 0.199, p = 0.813) on LF/HF power ratio. 
 
It was found that age was significantly associated with LF/HF (β = -0.052, p < 0.001), 
i.e. LF/HF decreased by 0.052 with an increase in age by one year. SFMPQII scores 
were also significantly associated with LF/HF (β = -0.010, p = 0.048), i.e. LF/HF 
decreased by 0.010 for each Pain Rating Index point. PCS scores and gender were 
not associated with LF/HF power ratio therefore not retained in this statistical model. 
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Figure 18. LF/HF power ratio 
Note: Intervention = epoch 1 and 2; post intervention = epochs 3, 4 and 5; LF = 
low frequency; HF = high frequency. 
 
Table 9. Statistical model results for LF/HF power ratio showing intervention 
and time effects/interaction with covariables that were retained in the model 
Variable β  (SE) p value 
   
Tape A -0.464 (0.389) 0.233 
Time, Post intervention -0.084 (0.394) 0.831 
Tape x Time interaction 0.199 (0.841) 0.813 
SFMPQII score -0.010 (0.005) 0.048 
Age -0.052 (0.014) 0.001 
Note: LF = low frequency; HF = high frequency; β = beta; SE = standard error; 
Tape A = experimental intervention; SFMPQII = Short-Form McGill Pain 
Questionnaire II. 
 
For participants who listened to the experimental intervention, LF/HF power ratio 
diminished by 0.464 over all time epochs compared to the control, implying a shift in 
sympathovagal tone toward the parasympathetic over 25 minutes. This was not 
significant though (p = 0.233) and does not support the hypothesis that a single 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
Epoch 1 Epoch 2 Epoch 3 Epoch 4 Epoch 5
L
F
/H
F
 
Experimental Control
61 
 
session body scan meditation will shift the ANS to a less sympathetic dominant state 
for people with chronic pain. 
4.6.4. Skin conductance response 
Comparison of experimental (Tape A) and control (Tape B) interventions for SCR is 
represented in Figure 19. Results are presented in Table 10. The estimate of the 
intervention effect was adjusted for potential confounding effects of age, gender, PCS 
and SFMPQII scores. 
 
 
Figure 19. SCR 
Note: Intervention = epoch 1 and 2; post intervention = epochs 3, 4 and 5; SCR 
= skin conductance response; µS = micro Siemens. 
 
There was no significant main effect of intervention (β = 0.546, p = 0.318) on SCR. 
SCR increased by 0.546µS across all time epochs for participants who received the 
experimental intervention. Time post intervention was significant (β = 1.356, p = 
0.014) on SCR but does not support the hypothesis that a single session body scan 
meditation will shift the ANS to a less sympathetic dominant state. There was no 
significant interaction effect of intervention x time (β = -0.470, p = 0.722). 
 
Age and gender were significantly associated with SCR (Table 10). An increase in 
age by one year reduced SCR by 0.104µS and males lowered SCR recordings by 
3.52µS across all time epochs. There was a minor trend of decreased SCR during 
both interventions but this was not maintained. PCS and SFMPQII scores were not 
associated with SCR therefore not retained in this statistical model. 
 
This result does not support the hypothesis that a single session body scan 
meditation will shift the ANS to a less sympathetic dominant state for people with 
chronic pain. 
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Table 10. Statistical model results for SCR showing intervention and time 
effects/interaction with covariables that were retained in the model 
Variable β  (SE) p value 
   
Tape A 0.546 (0.548) 0.318 
Time, Post intervention 1.356 (0.551) 0.014 
Tape x Time interaction -0.470 (1.323) 0.722 
Age -0.104 (0.020) 0.001 
Gender, Male -3.520 (0.620) 0.001 
Note: SCR = skin conductance response; β = beta; SE = standard error; Tape A 
= experimental intervention. 
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Chapter 5: Discussion 
The purpose of this study was to measure the immediate effects of a brief 
mindfulness body scan meditation on self-reported pain, the nociceptive system and 
autonomic nervous system. Results of this study showed no statistical differences 
between the group that listened to the experimental mindfulness tape and the group 
that listened to the control tape on any of the outcome measures. However, weak 
trends in reduced pain were observed for self-reported pain and pain sensitivity as 
measured by pressure pain thresholds for both groups. 
 
The weak trends observed for self-reported pain and PPTs are comparable to 
previous research findings indicating that mindfulness may be effective in reducing 
self-reported pain [88, 92-94]. Whilst the findings did not reach statistical significance 
and were common in the two groups, evidence of an effect from such a brief 
intervention warrants attention. This study was the first to investigate the effects of a 
brief mindfulness intervention on PPT and associated changes in the autonomic 
nervous system. The small sample size of 15 per group may have been 
underpowered, affecting the ability of the study to detect any statistically significant 
differences in nociception and autonomic indices. The study was powered for 
changes in VAS as the nociceptive and ANS outcome measures have not been 
previously investigated following a brief mindfulness intervention. Previous studies 
involving brief mindfulness strategies used sample groups ranging from 55 to 219 
participants and reported significant findings [88, 92, 93], suggesting that a larger 
number of participants may have been required to detect changes in the PPT and 
ANS variables. The trends in effect observed in PPTs and self-reported pain suggest 
the impact of brief mindfulness interventions is worthy of further investigation. 
 
As people with chronic pain were likely to find some aspects of an 8-week MBSR 
intervention challenging, this study explored the effects of a brief 10-minute 
mindfulness body scan intervention. The brevity of the intervention, using only one 
mindfulness technique (the body scan), may have precluded any significant effects 
on the autonomic and nociceptive systems from arising. Effects on the nociceptive 
and autonomic nervous system may occur as people become more skilled in using 
mindfulness. Indeed, studies of mindfulness meditation of 3 days [94] to 10 weeks 
[142, 143] have demonstrated and maintained improvement in perceptions of pain. 
As this was the first study to explore effects of a 10-minute mindfulness intervention 
on the nociceptive and autonomic nervous systems in people with chronic pain, 
further investigation of these outcomes is required in order to quantify the effects of a 
full MBSR programme. It was noted that, even when using a brief mindfulness 
intervention, physically some people were in so much pain they could not sit still for 
any length of time without discomfort. In the context of pain, the needs of this group 
were unique and had to be adapted for. Certain arm and leg positions had to be 
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adjusted for comfort due to conditions such as inflammatory arthritis, neuropathy or 
complex regional pain syndrome. This made the process of the participant perceiving 
and accurately recording their current level of pain challenging. 
 
To increase generalisability of the findings, participants with a range of chronic pain 
conditions were recruited for this study. There were six different pain conditions, 
including musculoskeletal and neurological conditions. Differences in the nature and 
presentation of these conditions may have influenced the results. For example, one 
participant who presented with Charcot-Marie Tooth Disease, an extremely sensitive 
demyelinating neuropathy, responded very differently to a person with a mild form of 
osteoarthritis. Indeed, for people with complex pain conditions, the physical act of 
mindfulness may have no impact or even cause negative effects [144]. The idea of 
mindfulness meditation is to become highly aware of the present moment, 
acknowledging and accepting feelings and sensations without getting caught up in 
their meaning or catastrophising them. Firstly, for people who might not even be able 
to sit comfortably, the act of directing focused attention may be too difficult when in 
chronic pain [144]. Secondly, for some people with chronic pain, mindfulness or 
focused attention is like shining a light on exactly what is wrong with them. The 
directed attention may make the experience of pain worse, heighten stress responses 
and lead to negative mood. These negative effects have been shown in a previous 
study involving mindfulness and cancer patients [144] but are generally the exception 
to the majority of participants’ responses. For the most part, mindfulness-based 
interventions of longer duration have been shown to support physical and social 
functioning [46], reduce pain-related behaviours [82] and improve and maintain 
chronic pain [84]. The effects of a brief mindfulness body scan meditation on 
nociception and the ANS observed across the conditions in this study had no effect 
but may be worth investigating in other conditions. It may be the case that 
mindfulness is more effective in some people and/or conditions than others. 
Unfortunately, due to the sample size in this study, this was not able to be explored, 
but exploration of the nature of responders and non-responders to mindfulness 
warrants investigation too. 
 
Use of the mindfulness approach has often been criticised for just being another 
relaxation strategy. However, advocates of the approach suggest that mindfulness 
works based on a number of mechanisms such as helping people to focus their 
attention, becoming more aware of their physical body, regulating their emotions and 
helping people to be more accepting of themselves rather than self-critical [145]. To 
control for the relaxation response, the control group were offered an intervention that 
had a relaxation effect to show if mindfulness had a greater effect than just a 
relaxation response. The findings of this study show that as there was no statistically 
significant difference between the two interventions of 10 minutes, and as both 
groups demonstrated weak trends of reduced self-reported pain and pain sensitivity, 
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a relaxation response was evident in both groups. In Chiesa et al’s [1] systematic 
review of mindfulness-based interventions for chronic pain, when mindfulness 
interventions are compared to active controls that exclude the active ingredient of 
mindfulness meditation, they usually show no significant advantage for the reduction 
of perceived pain. Indeed, other interventions revealing an effect of brief mindfulness 
used a distraction control group [92, 94]. The inclusion of a relaxation, usual care 
(non-treatment), or distraction control group may be helpful to explore this in more 
depth in future research. 
 
In addition, it is likely that participants may have been nervous or a little anxious 
about the research initially. After sitting still in a quiet room for 25 minutes, 
participants may have become acclimatised to the environment and more familiar and 
at ease with the researcher. As participants were likely to feel more relaxed, this may 
have influenced their pain ratings. The 15-minute rest period following the 
intervention was planned to assess for any carry-over effect from the intervention. All 
participants were novices to mindfulness meditation and therefore it was important to 
assess for carry-over effect of immediate skills learned (e.g. breathing deeply and 
sensorial awareness) into the period following the intervention. The study showed no 
statistically significant evidence of carry-over effects; however, an initial task not 
related to the study procedures could be used to help people feel more comfortable in 
the study environment before undertaking the interventions to help reduce any study 
evoked relaxation effects in the future. 
 
Both central and autonomic nervous system responses, including the electrodermal 
system, may be used as indicators for specific pain-related cognitive and emotional 
processing in people with various kinds of pain [146]. There was a significant effect of 
time on SCR, likely due to a large spike in SCR during epoch 3. When one is 
presented with a stimulus with a possible significant consequence, SCR increases 
are likely to occur in anticipation of that outcome. This is facilitated by descending 
cortical outputs to the ANS that mediate sympathetic SCR responses in anticipation 
of negative events [139]. Epoch 3 indicated the termination of the intervention and 
initiation of another assessment of the participant’s pain. It is speculated this meant 
returning to the real-world environment from an altered state, not being distracted 
from the pain anymore if that were the case, drawing attention to the pain, and then 
having the researcher induce a nociceptive response with an algometer. The latter 
would induce both a sensory and affective pain response, which would most likely be 
the reason for the SCR spike at epoch 3. 
 
The findings on self-reported pain may also have been influenced by the outcome 
measures used. Even though results indicated a steep decrease in VAS scores for 
both intervention groups, there are inherent errors and controversies with the use of 
VAS. VAS was chosen as an outcome measure for this study because it requires little 
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training to administer and score, and has been found to be adaptable to a broad 
range of populations and settings [132]. Research suggests though that people can 
find it difficult to judge how to rate their pain on the VAS line [147]. DeLoach et al 
[148] found that a single VAS measurement has an imprecision of 20mm when 
measuring acute pain and suggested that clinically significant changes in pain 
sensation would require a change in VAS score of similar magnitude. This should be 
considered when interpreting changes in VAS scores in clinical practice. A recent 
study [149] also highlighted the lack of sensitivity of the VAS pain scale to distinguish 
between groups of people with different pain levels and/or pain conditions. It is known 
that the margin of error increases non-linearly in VAS scores with an increase in 
severity of pain [134], while the scale remains more linear with mild to moderate pain. 
With the vast degree in difference of pain conditions in this study, VAS scores would 
most likely have changed non-linearly in this fashion. Pain is a difficult construct to 
measure due to its subjectivity and because it is comprised of both sensory and 
affective components. 
 
Results of this study showed that PCS scores were significantly associated with VAS 
scores and therefore how people felt about their pain. Higher levels of pain 
catastrophising is known to influence the intensity of pain in people with chronic pain 
[38]. In this study, every PCS point increased VAS by almost a millimetre. The 
participants were a varied group of complex chronic pain syndromes with almost half 
the sample scoring above the 50
th
 percentile on the pain catastrophising scale. 
Previous brief mindfulness studies had all used healthy students [92-94] and did not 
include cognitive evaluations of how the participants felt about their condition. Many 
people applied to this study looking for hope of long term resolution and may have 
responded differently to the interventions compared to healthy people. Including 
healthy participants as a control might also be a consideration for future research. 
 
Gender was found to significantly affect PPT ratings. It is speculated that the 
possibilities for higher PPT ratings of males included, but were not limited to: the 
nature of their condition being less severe to them psychologically (low PCS score); 
possessing a less sensitive condition than other participants, e.g. musculoskeletal 
versus demyelinating neuropathy; or socially desirable responding when providing 
pain responses to the researcher. Socially desirable responding is the tendency for 
participants to present a favourable image of themselves on questionnaires, which 
can obscure results [150]. It is possible some of these males did not want to present 
themselves in a light of suffering and therefore offered scores that were higher than 
what they may truly have been. Social desirability reporting therefore needs to be 
taken into account when exploring the effects of mindfulness. 
 
While PPT measurement has demonstrated reliability and validity as a diagnostic tool 
[104], it may also possess inherent errors as an outcome measure for people with 
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chronic pain. Ohrbach et al [151] proposed that examiner expectancy could affect 
PPT results. Firstly, a researcher may unintentionally and unconsciously manipulate 
the rate of pressure application of the PPT device, causing an increase or decrease 
in PPT. Secondly, if the researcher is expecting a certain value for a painful or non-
painful site, he or she may increase or decrease the rate of pressure application 
based on this expectancy, especially if the participant has not given the signal to stop 
the pressure. For example, at a painful site, if the researcher is not watching for facial 
cues of pain and the participant has forgotten to signal stop, then the researcher may 
slow down the rate of pressure application because they believe to be reaching a 
PPT ceiling. Whereas at the non-painful site, the researcher may be more cavalier 
with the rate of pressure because they are less concerned with hurting the person. 
Both scenarios could potentially skew results. Despite these potential errors, there 
are still reliable differences in previous studies between PPT recordings of painful 
and control sites [151] and this has been demonstrated in this study with non-painful 
PPT site measurements being significantly higher than painful PPT site 
measurements. 
 
Another potential PPT error is a reduced reading due to temporal summation. 
Temporal summation is defined as a progressive increase in pain perception caused 
by a sequence of somatosensory stimuli of the same intensity [107]. When applying 
pressure with an algometer at the same painful site twice in a row, a person with 
central sensitisation might exhibit a lower PPT on the second application of pressure 
due to the facilitated temporal summation of pain. This effect was accommodated for 
in this study by alternating PPT recordings between the painful site and the non-
painful site when averaging two recordings. 
 
Normalised spectral HRV measures were used in this study because the 
normalisation process expresses values on a more easily understood proportion (0-
1), or percentage scale basis, and removes most of the large within and between-
subject variability in the total raw HRV spectral power [137]. Furthermore, normalised 
HF was selected over normalised LF as an indicator of intervention effect on ANS 
activity because the higher frequency spectral bands are more indicative of 
parasympathetic activity only [114, 137]. This is because there is controversy 
surrounding the make-up of low frequency spectral bands with some studies 
considering LF to reflect both sympathetic and vagal activity [119]. Therefore, even 
though LF was recorded and analysed, it was not presented in the results of this 
study. 
 
It is also common for research papers to present nuHF and the LF/HF ratio conjointly 
[137], with the former as an index of parasympathetic activity and the latter an index 
of sympathovagal balance between the two autonomic branches, implying that they 
are two independent variables each with distinct physiologic interpretation. However, 
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as Burr [137] points out, normalised spectral HRV indices nuLF and nuHF are each 
linked to the LF/HF ratio with simple reversible 1-to-1 mappings, i.e. nuLF and nuHF 
are each exactly predictable from the LF/HF ratio and vice versa. This is another 
reason why nuHF was chosen in this study over nuLF. The LF/HF power ratio was 
analysed and presented but produced no statistically significant differences between 
the groups. 
 
Results for nuHF showed no statistical difference between the groups listening to 
either intervention tape. The weak trend observed though was that the experimental 
mindfulness group showed reduced parasympathetic activity, which is in contrast to a 
previous study [114] looking at meditation and nuHF. That study involved 5 days of 
integrative body-mind training with healthy people however, which is a significantly 
longer period of time than a 10-minute body scan meditation. No other brief 
mindfulness studies to date [88, 92-94] have looked specifically at autonomic activity 
as it relates to chronic pain therefore it is difficult to draw any comparisons. Ditto et al 
[89] has been the only one to look at the effects of a brief mindfulness body scan 
meditation on the ANS to date but, again, used healthy participants. Their results 
were also mixed because a decrease in respiration rate shifts parasympathetically 
mediated RSA to lower frequencies by increasing cardiac sympathetic activity. In our 
study, the body scan meditation intervention involved a slowing of respiration rate, 
which might explain the reduction in parasympathetic activity for the experimental 
group if meditation is known to increase cardiac sympathetic activity. A slowing of 
respiration rate would reduce mean HR and this was a weak trend observed in this 
study across all time epochs for the experimental group, consistent with Ditto et al’s 
[89] findings for a brief body scan meditation. A trend of decreased parasympathetic 
activity echoes Ditto et al’s [89] sentiment that meditation can involve active, arousal 
promoting processes; however, meditation alone cannot account for the reduction in 
parasympathetic activity for people with chronic pain. Cortical and psychological 
influences through midline structures such as the ACC can influence the ANS [112], 
as was observed in the third SCR epoch. The affective component of physically being 
in pain, and drawing attention to that pain, will most likely modulate the ANS to 
engage both sympathetic and parasympathetic activity. HRV frequency results of a 
complex pain group would be more challenging to interpret compared to a group of 
healthy individuals due to the complex outputs of the central and autonomic nervous 
systems. 
 
Older age was shown to reduce mean HR, increase nuHF, decrease LF/HF, and 
decrease SCR. The median age of both sample groups was 60 years. Aging effects 
the plasticity of the ANS including loss of neurons, loss of axonal branches and 
alterations in neurotransmitter release [152, 153]. Cell loss has been demonstrated in 
the interomediolateral cell column of the spinal cord of the elderly, resulting in 
reduced density of sympathetic nerve endings [153]. It has also been suggested that 
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there is age-related reduction in sympathetic β-adrenergic drive to the heart, together 
with a decrease in β-adrenergic sensitivity in older people [152]. In fact, many 
cardiovascular reflexes show altered responsiveness with aging, including respiratory 
sinus arrhythmia and vagal baroreflexes [153]. This would most likely result in a 
reduction of HR and elevation of parasympathetic activity. 
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Chapter 6: Conclusion 
The purpose of this study was to measure the immediate effects of a brief 
mindfulness body scan meditation on self-reported pain, the nociceptive system and 
autonomic nervous system. In people with chronic pain, a brief mindfulness body 
scan meditation has no effect on rating of pain severity on a visual analogue scale, 
pressure pain thresholds, mean heart rate, heart rate variability, heart rate variability 
low frequency to high frequency power ratio, or skin conductance when compared to 
a control group. Further research is required before determining whether brief 
mindfulness interventions are helpful in people experiencing chronic pain. 
 
Previous evidence suggests that mindfulness may positively influence the experience 
of pain but results of this study suggest that individuals may need to become more 
skilled in mindfulness techniques over longer periods of time in order for mindfulness 
to potentially have greater, longer-lasting effects. 
 
Brief mindfulness has been shown to have an effect on pain ratings and the 
autonomic nervous system of healthy people; however, its effect on complex pain 
conditions did not present with similar findings in this study. Parameters such as the 
nature of the pain condition, length of the intervention, sample size, outcome 
measures used, carry-over effect, environment, positioning, age, gender, social 
desirability and pain catastrophising are all complex factors that have may 
contributed to the results of this study. 
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Chapter 7: Limitations 
The following limitations apply to this study: 
 
A. The sample size may have been underpowered to detect statistically significant 
differences in the ANS outcome measures. No previous brief mindfulness studies 
have thus far investigated the nociceptive and autonomic nervous system 
together. 
B. Differences in the nature and presentation of the complex pain conditions in this 
study may have influenced results. Mindfulness meditation may be more effective 
in some people and/or conditions than others. 
C. The ANS outcome measures were not assessed prior to the interventions. A 
longer baseline period would ensure that participants were suitably comfortable 
with the study environment and baseline recordings could be obtained for the 
ANS outcome measures. 
D. Age was shown to influence the ANS outcome measures and may have 
influenced the efficacy of the interventions. 
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Chapter 8: Further research 
A number of areas of further research have been identified during the course of this 
study which include, but are not limited to: 
 
A. Determining the effect of an 8-week MBSR programme on the autonomic and 
nociceptive nervous systems. 
B. Performing a randomised control trial of brief mindfulness on people with chronic 
pain; on sensory and affective self-reported pain; using both a relaxation and 
usual care control group. 
C. Exploring the influence of age on the autonomic nervous system and how this 
may influence the response to pain treatments. 
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